Page last updated: 2024-10-16

ammonium hydroxide and Disease Models, Animal

ammonium hydroxide has been researched along with Disease Models, Animal in 281 studies

azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" Urea cycle disorders with hyperammonemia remain difficult to treat and eventually necessitate liver transplantation."8.12Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model. ( Burczynski, ME; Chen, H; Cheng, X; Halasz, G; Kim, S; Lin, AZ; Mao, X; Murphy, AJ; Na, E; Okamoto, H; Sleeman, MW, 2022)
" Low-grade chronic liver failure (CLF) was induced in 3-month old Sprague-Dawley male rats using thioacetamide (TAA, 50 mg·kg-1·day-1) intraperitoneally for 2 weeks."7.85Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats. ( Ali, SS; Gazzaz, ZJ; Ibraheem, MS; Murad, HA, 2017)
"Short-term administration of Galactosamine to experimental animals causes liver damage and acute liver failure (ALF), as well as acute renal failure in some cases."7.81D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? ( Brytan, M; Dyrla, P; Gil, J; Kade, G; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Zdanowski, R, 2015)
"Citrullinemia type 1 (CTLN1) is an autosomal recessive disorder of metabolism caused by a deficiency of argininosuccinate synthetase."7.79Liver-directed adeno-associated virus serotype 8 gene transfer rescues a lethal murine model of citrullinemia type 1. ( Chandler, RJ; Cusmano-Ozog, K; McGuire, PJ; Sun, Q; Sutton, VR; Tarasenko, TN; Venditti, CP, 2013)
" The present study was undertaken to examine the protective influence of rutin, a polyphenolic flavonoid, on oxidative stress during ammonium chloride (AC)-induced hyperammonemia by measuring the levels of oxidative damage as well as antioxidant status."7.78Influence of rutin on biochemical alterations in hyperammonemia in rats. ( Mahmoud, AM, 2012)
" We examined the modulatory effect of the type 1 angiotensin II receptor blocker losartan on the ability of metabolic acidosis to stimulate ammonia production and secretion by mouse S2 proximal tubule segments."7.74Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis. ( Nagami, GT, 2008)
"The objective of this study was to evaluate a new method for the treatment of acute hyperammonemia with a helium-oxygen mixture (heliox)."7.71Heliox use in the treatment of acute hyperammonemia. ( Barr, J; Chen-Levy, Z; Eshel, G; Lahat, E, 2001)
"Therapeutic modulation of the increased GABAergic tone in chronic hepatic encephalopathy (HE) by the benzodiazepine receptor (BR) antagonist flumazenil (F) has led to conflicting results in humans and animal models for HE."7.70Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil. ( Legemate, DA; Meyer, HP; Rothuizen, J; van den Brom, W, 1998)
"Hepatic encephalopathy in patients with severe liver disease was associated with marked elevation of either serum methionine or blood ammonia levels or with simultaneous moderate increases in both parameters."7.66Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy. ( Higashi, T, 1982)
" One of the biggest problems of these compounds, however, is their very short bioavailability due to instant metabolism and rapid excretion."5.51Poly(ornithine)-based self-assembling drug for recovery of hyperammonemia and damage in acute liver injury. ( Ibayashi, Y; Lee, Y; Nagasaki, Y; Ngo, DN; Nishikawa, Y; Vong, LB, 2019)
"Treatment with rutin resulted in improvement in liver function by the decline in serum AST and ALT activities and reduction in serum ammonia level."5.46Ameliorative effects of rutin on hepatic encephalopathy-induced by thioacetamide or gamma irradiation. ( El-Marakby, SM; Mansour, SZ; Moawed, FSM, 2017)
"Hepatic encephalopathy is a severe neuropathological condition arising secondary to liver failure."5.35Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. ( Bak, LK; Iversen, P; Keiding, S; Ott, P; Schousboe, A; Sørensen, M; Vilstrup, H; Waagepetersen, HS, 2009)
"The rationale for recommendation of branched-chain amino acids (BCAA; valine, leucine, and isoleucine) in treatment of liver failure is based on their unique pharmacologic properties, stimulatory effect on ammonia detoxification to glutamine (GLN), and decreased concentrations in liver cirrhosis."4.89Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications. ( Holecek, M, 2013)
"Life-threatening hyperammonemia occurs in both inherited and acquired liver diseases affecting ureagenesis, the main pathway for detoxification of neurotoxic ammonia in mammals."4.12O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis. ( Arena, P; Attanasio, S; Boffa, I; Brunetti-Pierri, N; Cuomo, P; D'Alessio, AM; De Angelis, A; Desviat, LR; Ferenbach, AT; Häberle, J; Lipshutz, GS; Makris, G; Martínez-Pizarro, A; Motta, A; Nitzahn, M; Nusco, E; Paris, D; Pravata, VM; Richard, E; Rüfenacht, V; Soria, LR; van Aalten, DMF, 2022)
" Urea cycle disorders with hyperammonemia remain difficult to treat and eventually necessitate liver transplantation."4.12Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model. ( Burczynski, ME; Chen, H; Cheng, X; Halasz, G; Kim, S; Lin, AZ; Mao, X; Murphy, AJ; Na, E; Okamoto, H; Sleeman, MW, 2022)
"Arginase deficiency is caused by biallelic mutations in arginase 1 (ARG1), the final step of the urea cycle, and results biochemically in hyperargininemia and the presence of guanidino compounds, while it is clinically notable for developmental delays, spastic diplegia, psychomotor function loss, and (uncommonly) death."3.91Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency. ( Allegri, G; Burke, KE; Cederbaum, SD; Häberle, J; Lipshutz, GS; Liu, XB; Martini, PGV; Truong, B; Zhu, X, 2019)
" Low-grade chronic liver failure (CLF) was induced in 3-month old Sprague-Dawley male rats using thioacetamide (TAA, 50 mg·kg-1·day-1) intraperitoneally for 2 weeks."3.85Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats. ( Ali, SS; Gazzaz, ZJ; Ibraheem, MS; Murad, HA, 2017)
"Short-term administration of Galactosamine to experimental animals causes liver damage and acute liver failure (ALF), as well as acute renal failure in some cases."3.81D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? ( Brytan, M; Dyrla, P; Gil, J; Kade, G; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Zdanowski, R, 2015)
"Citrullinemia type 1 (CTLN1) is an autosomal recessive disorder of metabolism caused by a deficiency of argininosuccinate synthetase."3.79Liver-directed adeno-associated virus serotype 8 gene transfer rescues a lethal murine model of citrullinemia type 1. ( Chandler, RJ; Cusmano-Ozog, K; McGuire, PJ; Sun, Q; Sutton, VR; Tarasenko, TN; Venditti, CP, 2013)
" Current knowledge suggests that hyperammonemia, related to liver failure, is a main factor contributing to the cerebral alterations in HE and that hyperammonemia might impair signal transduction associated with post-translational modification of proteins such as tyrosine-nitration and phosphorylation."3.78Exploratory investigation on nitro- and phospho-proteome cerebellum changes in hyperammonemia and hepatic encephalopathy rat models. ( Airoldi, L; Boix, J; Brunelli, L; Campagna, R; Cauli, O; Felipo, V; Llansola, M; Pastorelli, R, 2012)
" The present study was undertaken to examine the protective influence of rutin, a polyphenolic flavonoid, on oxidative stress during ammonium chloride (AC)-induced hyperammonemia by measuring the levels of oxidative damage as well as antioxidant status."3.78Influence of rutin on biochemical alterations in hyperammonemia in rats. ( Mahmoud, AM, 2012)
"Ornithine phenylacetate (OP) is a new drug that has been proposed for the treatment of hepatic encephalopathy (HE) because it decreases plasma ammonia."3.78Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. ( Arranz, JA; Córdoba, J; Oria, M; Raguer, N; Riudor, E; Romero-Giménez, J, 2012)
"Hyperammonemia is a frequent side-effect of valproic acid (VPA) therapy, which points to an imbalance between ammoniagenesis and ammonia disposal via the urea cycle."3.77New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. ( Aires, CC; de Almeida, IT; Duran, M; Ijlst, L; Silva, MF; van Cruchten, A; Wanders, RJ, 2011)
" The aim of this study was to assess the effects of simvastatin on rats with TAA-induced acute liver damage and hepatic encephalopathy."3.74Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy. ( Chan, CY; Chang, FY; Chen, YC; Chu, CJ; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS, 2008)
" plantarum strains were administered in ornithine transcarbamoylase-deficient Sparse-fur mice, a model of constitutive hyperammonemia, in a carbon tetrachloride rat model of chronic liver insufficiency and in a thioacetamide-induced acute liver failure mice model."3.74Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. ( Demetter, P; Devière, J; Goffin, P; Gustot, T; Hols, P; Moreno, C; Nicaise, C; Prozzi, D; Quertinmont, E; Suain, V; Viaene, E, 2008)
" Liver failure with significant increase in serum concentration of bilirubin, alanine transaminase (ALT) and ammonia, as well as huge microscopic necrosis of hepatocytes developed in both groups, but we did not achieved any evidence of acute renal failure in Wistar rats group."3.74[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]. ( Kozłowski, W; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Wesołowski, P, 2008)
" We examined the modulatory effect of the type 1 angiotensin II receptor blocker losartan on the ability of metabolic acidosis to stimulate ammonia production and secretion by mouse S2 proximal tubule segments."3.74Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis. ( Nagami, GT, 2008)
"To assess whether portacaval anastomosis (PCA) in rats affects the protein expression and/or activity of glutaminase in kidneys, intestines and in three brain areas of cortex, basal ganglia and cerebellum and to explain the neurological alterations found in hepatic encephalopathy (HE)."3.73Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis. ( Bautista, JD; Camacho, I; de Teran, LC; Diaz-Gomez, D; Echevarria, M; Felipo, V; Jover, M; Rodrigo, R; Romero-Gomez, M, 2006)
" Liver failure developed with significant increase in serum concentration of bilirubin, AST, ALT; ammonia and massive necrosis of hepatocytes."3.72[Description of an experimental model of hepatorenal syndrome in Wistar rats]. ( Kozłowski, W; Saracyn, M; Wańikowicz, Z, 2004)
" Indomethacin induced gastritis but without atrophy, and short-term vitamin deficiency failed to induce chronic gastritis and gastric atrophy."3.72Chronic gastritis rat model and role of inducing factors. ( Huang, HD; Si, JM; Xiang, Z, 2004)
" We have conducted studies to determine whether the protection afforded by the administration of sodium bicarbonate is sustained and prevents development of uremia during chronic administration and whether the effects of the administration of ammonium chloride and sodium bicarbonate are also observed in a different model of polycystic kidney disease, the CD1-pcy/pcy mouse."3.71Long-term ammonium chloride or sodium bicarbonate treatment in two models of polycystic kidney disease. ( Branden, MG; Cowley, BD; Gattone, VH; Torres, VE; Yoshida, I, 2001)
"The objective of this study was to evaluate a new method for the treatment of acute hyperammonemia with a helium-oxygen mixture (heliox)."3.71Heliox use in the treatment of acute hyperammonemia. ( Barr, J; Chen-Levy, Z; Eshel, G; Lahat, E, 2001)
"Therapeutic modulation of the increased GABAergic tone in chronic hepatic encephalopathy (HE) by the benzodiazepine receptor (BR) antagonist flumazenil (F) has led to conflicting results in humans and animal models for HE."3.70Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil. ( Legemate, DA; Meyer, HP; Rothuizen, J; van den Brom, W, 1998)
"Portocaval shunt with common bile duct transection produces liver failure with elevations in aminotransferases, total bilirubin, and ammonia, a decreased branched chain to aromatic amino acid ratio, and histologic inflammation."3.70A novel stable reproducible model of hepatic failure in canines. ( Awad, SS; Bartlett, RH; Gargulinski, M; Hemmila, MR; Hirschl, RB; Mahler, S; Rich, PB; Sawada, S; Soldes, OS, 2000)
"Intracerebral microdialysis was applied to monitor the neocortical extracellular levels of the aromatic amino acids phenylalanine, tyrosine, and tryptophan, the neurotransmitters dopamine (DA), noradrenaline (NA), and serotonin (5-HT), and the metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindole-3-acetic acid (5-HIAA) in rats with various forms of experimental hepatic encephalopathy (HE)."3.69Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. ( Bengtsson, F; Bergqvist, PB; Bosman, DK; Chamuleau, RA; Hjorth, S; Maas, MA; Vogels, BA, 1995)
"We investigated the role of brain peripheral-type benzodiazepine receptors (PBRs) and pregnenolone (a product of PBRs activation) in hepatic encephalopathy (HE)/hyperammonemia."3.69Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. ( Dombro, RS; Itzhak, Y; Norenberg, MD; Roig-Cantisano, A, 1995)
"To obtain a more precise pathophysiological evaluation of the role of ammonia in acute hepatic encephalopathy, we compared the plasma ammonia concentrations and electroencephalographic recordings (EEGs) of rabbits with surgically induced acute hepatic failure (AHF, n = 10) and normal rabbits administered an infusion of ammonium acetate (NH4-Ac, n = 7) over a 10-hr period."3.67Continuous intravenous ammonia infusion as a model for the study of hepatic encephalopathy in rabbits. ( de Vlieger, M; Fick, TE; Schalm, SW, 1989)
"To assess neuronal mechanisms of potential importance in the pathogenesis of hepatic encephalopathy, visual evoked potentials were recorded in rabbits with acute hyperammonemic encephalopathy, postictal coma, and toxin-induced coma resulting from the administration of a combination of subcoma doses of three neurotoxins: ammonia, dimethyldisulfide, and octanoic acid."3.67Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. ( Ferenci, P; Jones, EA; Pappas, SC; Schafer, DF, 1984)
"Hepatic encephalopathy in patients with severe liver disease was associated with marked elevation of either serum methionine or blood ammonia levels or with simultaneous moderate increases in both parameters."3.66Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy. ( Higashi, T, 1982)
"Hyperammonemia is a feature of liver failure, which is associated with increased risk of infection."2.73Ammonia impairs neutrophil phagocytic function in liver disease. ( Davies, NA; Hodges, SJ; Jalan, R; Pitsillides, AA; Shawcross, DL; Stadlbauer, V; Wheeler-Jones, C; Wright, GA, 2008)
"Mycophenolic acid was detected in all cats."2.61 ( Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019)
"The current treatments for hyperammonemia, such as antibiotics or lactulose, are designed to decrease the intestinal production of ammonia and/or its absorption into the body and are not effective, besides being often accompanied by side effects."2.58The Pharmabiotic Approach to Treat Hyperammonemia. ( Chung, HJ; Hong, ST; Kim, HJ; Liu, J; Lkhagva, E, 2018)
"In regards to hepatic encephalopathy, however, the CCl4 cirrhosis rat model seems to display few behavioral changes unless very advanced decompensated cirrhosis is produced."2.39Animal models of hepatic encephalopathy and hyperammonemia. ( Birgisson, S; Conjeevaram, H; Gacad, RC; Mullen, KD, 1994)
"We successfully established a reproducible Tibetan miniature pig model of d-galactosamine-induced ALF, and we believe that a dosage of 0."1.91Establishment of acute liver failure model in Tibetan miniature pig and verified by dual plasma molecular adsorption system. ( Cai, L; Feng, L; Fu, Y; Gao, Y; Jiang, Z; Liu, S; Wang, Y; Xu, X; Zhang, L; Zhou, C, 2023)
"In nonalcoholic fatty liver disease (NAFLD), fibrosis is the most important factor contributing to NAFLD-associated morbidity and mortality."1.56Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease. ( Andreola, F; Davies, N; De Chiara, F; Gracia-Sancho, J; Habtesion, A; Hall, A; Jalan, R; Jones, H; Leslie, J; Manicardi, N; Mann, J; Mookerjee, RP; Oakley, F; Paish, HL; Reed, LH; Rombouts, K; Thomsen, KL; Watson, AA, 2020)
"Methylenedioxymethamphetamine (MDMA) and methcathinone (MCAT) are abused psychostimulant drugs that produce adverse effects in human users that include hepatotoxicity and death."1.56High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone. ( Chen, Y; Hall, FS; Saber, YH; Tran, HTN, 2020)
"Inflammation is likely an important target of BBD to treat HE."1.56BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. ( An, YT; Bahaji Azami, NL; Lu, BJ; Lu, L; Sun, MY; Wang, HJ; Wang, Z; Wu, C; Xie, D; Ye, G, 2020)
" One of the biggest problems of these compounds, however, is their very short bioavailability due to instant metabolism and rapid excretion."1.51Poly(ornithine)-based self-assembling drug for recovery of hyperammonemia and damage in acute liver injury. ( Ibayashi, Y; Lee, Y; Nagasaki, Y; Ngo, DN; Nishikawa, Y; Vong, LB, 2019)
"The development of fibrosis is the most important factor contributing to NASH-associated morbidity and mortality."1.48Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis. ( Andreola, F; De Chiara, F; Jalan, R; Mookerjee, RP; Rombouts, K; Thomsen, KL; Vilstrup, H, 2018)
"Neurological symptoms of acute liver failure (ALF) reflect decreased excitatory transmission, but the status of ALF-affected excitatory synapse has not been characterized in detail."1.48Cortical Synaptic Transmission and Plasticity in Acute Liver Failure Are Decreased by Presynaptic Events. ( Albrecht, J; Bobula, B; Filipkowski, RK; Frontczak-Baniewicz, M; Hess, G; Polowy, R; Popek, M; Sowa, J; Zabłocka, B; Zielińska, M, 2018)
"Hyperammonemia is a common finding in patients with methylmalonic acidemia."1.48Ammonia role in glial dysfunction in methylmalonic acidemia. ( Arend, J; Barbosa, S; do Nascimento, PS; Dos Santos, ARS; Fighera, MR; Furian, AF; Gabbi, P; Haupental, F; Nogueira, V; Oliveira, MS; Rodrigues, FS; Royes, LFF, 2018)
"We successfully established a simplified, reproducible D-galactosamine-induced cynomolgus monkey model of acute liver failure, and the single or divided dosage of 0."1.46Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure. ( Cai, L; Feng, L; Gao, Y; He, GL; Jiang, ZS; Li, Y; Pan, MX; Peng, Q; Weng, J, 2017)
"Treatment with rutin resulted in improvement in liver function by the decline in serum AST and ALT activities and reduction in serum ammonia level."1.46Ameliorative effects of rutin on hepatic encephalopathy-induced by thioacetamide or gamma irradiation. ( El-Marakby, SM; Mansour, SZ; Moawed, FSM, 2017)
"Hyperammonemia is a consistent abnormality in cirrhosis that results in impaired skeletal muscle protein synthesis and breakdown (proteostasis)."1.46Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. ( Dasarathy, S; Davuluri, G; Deutz, NEP; Engelen, MPKJ; Kumar, A; Prayson, R; Silva, RNE; Ten Have, GAM, 2017)
"Muscle mass loss and hepatic encephalopathy (complex neuropsychiatric disorder) are serious complications of chronic liver disease (cirrhosis) which impact negatively on clinical outcome and quality of life and increase mortality."1.46The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis. ( Bemeur, C; Bosoi, CR; Deutz, NE; Ochoa-Sanchez, R; Oliveira, MM; Rose, CF; Ten Have, GA; Tremblay, M, 2017)
"Understanding the seizure-inducing mechanisms of TBI is of the utmost importance, because these seizures are often resistant to traditional first- and second-line anti-seizure treatments."1.46NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility. ( Cotrina, ML; Gu, S; He, X; Huang, JH; Liu, W; Nedergaard, M; Shapiro, LA; Wang, EW; Wang, F; Wang, W; Wang, X, 2017)
"The pathogenesis of hepatic encephalopathy (HE) in cirrhosis is multifactorial and ammonia is thought to play a key role."1.46Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease. ( Davies, N; De Chiara, F; Gourine, AV; Habtetion, A; Hadjihambi, A; Hosford, PS; Jalan, R; Karagiannis, A, 2017)
" Rifaximin, a poorly absorbed antibiotic that targets gut flora, significantly improved symptoms of HE."1.43Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin. ( Fukui, N; Isobe, M; Okada, M; Saito, T; Suzuki, H; Tamaoki, S, 2016)
"Hyperammonemia is less severe in arginase 1 deficiency compared with other urea cycle defects."1.42Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy. ( Cantero, G; Cantero-Nieto, G; Cederbaum, SD; Chan, E; Hu, C; Lipshutz, GS; Park, H; Tai, DS; Yudkoff, M, 2015)
"Glycine is an important ammoniagenic amino acid, which is increased in acute liver failure (ALF)."1.40L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway. ( Fuskevåg, OM; Jalan, R; Kristiansen, RG; Mæhre, H; Revhaug, A; Rose, CF; Ytrebø, LM, 2014)
"In a rat model of chronic liver failure, hyperammonemia is associated with inadequate compensation by liver and muscle GS activity and increased gut GA activity."1.40Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats. ( Davies, N; Habtesion, A; Jalan, R; Jover-Cobos, M; Lee, K; Noiret, L; Romero-Gomez, M; Sharma, V, 2014)
"Mortality of patients with acute liver failure (ALF) is still unacceptably high."1.39Evaluation of the Hepa Wash® treatment in pigs with acute liver failure. ( Al-Chalabi, A; Huber, W; Kreymann, B; Luppa, P; Matevossian, E; Nairz, E; Neiss, A; Perren, A; Radermacher, P; Schimmel, P; Schmid, RM; Schreiber, C; Schuster, T; V Thaden, AK; Yang, Z, 2013)
"Uric acid has also antioxidant properties and is a surrogate marker of metabolic syndrome."1.38Long-term activation of semicarbazide-sensitive amine oxidase lowers circulating levels of uric acid in diabetic conditions. ( Carpéné, C; Desquesnes, A; Gomez-Ruiz, A; Iffiú-Soltész, Z; Le Gonidec, S; Mercader, J, 2012)
" The results show that a binge dosing regimen of METH to the rat increased plasma and brain ammonia concentrations that were paralleled by evidence of hepatotoxicity."1.38Peripheral ammonia as a mediator of methamphetamine neurotoxicity. ( Halpin, LE; Yamamoto, BK, 2012)
"is widely used for the treatment of cough, bronchitis and asthmatic disorders in the Traditional Chinese Medicine."1.38Metabolomic profiling of the flower bud and rachis of Tussilago farfara with antitussive and expectorant effects on mice. ( Jia, JP; Li, ZY; Qin, XM; Sun, HF; Xing, J; Xue, SY; Zhang, FS; Zhang, LZ; Zhi, HJ, 2012)
"However, HE in patients with liver cirrhosis is not associated with an up-regulation of inflammatory cytokines in cerebral cortex, despite microglia activation."1.37Microglia activation in hepatic encephalopathy in rats and humans. ( Bidmon, HJ; Görg, B; Häussinger, D; Keitel, V; Schrör, K; Zemtsova, I, 2011)
"The pathophysiology of cerebral edema in ALF is incompletely understood."1.37Ammonia-induced brain swelling and neurotoxicity in an organotypic slice model. ( Back, A; Bai, T; Brorson, JR; Chiranand, P; Frank, JI; Goldenberg, FD; Tupper, KY, 2011)
"Acute liver failure was surgically induced in swine by complete hepatectomy (n = 8)."1.37Neuromonitoring in a porcine model of acute hepatic failure. ( Frühauf, NR; Grabellus, F; Kaiser, GM; Laube, T; Radunz, S; Uerschels, AK, 2011)
"Hyperammonemia is considered to be the main cause of decreased levels of the branched-chain amino acids (BCAA), valine, leucine, and isoleucine, in liver cirrhosis."1.37Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle. ( Holecek, M; Kandar, R; Kovarik, M; Sispera, L, 2011)
"To develop a reliable surgical model of acute hepatic failure and hyperammonemia in rats that avoids porto-systemic shunt and bile duct ligation, applicable to hepatic encephalopathy research."1.36A new experimental model for acute hepatic failure in rats. ( Bellodi-Privato, M; D'Albuquerque, LA; Kubrusly, MS; Leite, KR; Machado, MC; Molan, NT; Teixeira, AR, 2010)
"Hyperammonemia is a main contributor to brain herniation and mortality in acute liver failure (ALF)."1.35Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain. ( Agusti, A; Boix, J; Cauli, O; Felipo, V; Piedrafita, B; Rodrigo, R, 2008)
"Myocardial infarction was induced by mid-left anterior descending coronary artery balloon occlusion in 11 pigs."1.35Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. ( Abraham, MR; Ashikaga, H; Bengel, FM; Chang, KC; Dannals, RF; Dong, J; Halperin, H; Hilton, J; Holt, DP; Lardo, AC; Marbán, E; Mills, KJ; Nekolla, SG; Sasano, T, 2008)
"After transplantation into mice with acute liver failure, ASC-derived hepatocytes can restore such liver functions as ammonia and purine metabolism."1.35Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. ( Banas, A; Kato, T; Ochiya, T; Okochi, H; Osaki, M; Takeshita, F; Teratani, T; Tokuhara, M; Yamamoto, Y, 2009)
"Hepatic encephalopathy is a severe neuropathological condition arising secondary to liver failure."1.35Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. ( Bak, LK; Iversen, P; Keiding, S; Ott, P; Schousboe, A; Sørensen, M; Vilstrup, H; Waagepetersen, HS, 2009)
"Patients with acute liver failure (ALF) display impairment of cerebral blood flow (CBF) autoregulation, which may contribute to the development of fatal intracranial hypertension, but the pathophysiological mechanism remains unclear."1.35Cerebral blood flow autoregulation in experimental liver failure. ( Dethloff, TJ; Knudsen, GM; Larsen, FS, 2008)
"LPS induced cytotoxic brain swelling and maintained anatomical integrity of the blood-brain barrier."1.34Endotoxemia produces coma and brain swelling in bile duct ligated rats. ( Brooks, HF; Davies, C; Davies, NA; Harry, D; Hodges, SJ; Jalan, R; Mani, AR; Moore, KP; Shawcross, DL; Stadlbauer, V; Williams, R; Wright, G; Zou, Z; Zwingmann, C, 2007)
"We previously demonstrated in pigs with acute liver failure (ALF) that albumin dialysis using the molecular adsorbents recirculating system (MARS) attenuated a rise in intracranial pressure (ICP)."1.34Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. ( Belanger, M; Davies, NA; Jalan, R; Nedredal, GI; Revhaug, A; Rose, C; Sen, S; Ytrebø, LM, 2007)
"The initial development of cerebral edema and increased ICP occurs independently of CBF changes in this noninflammatory model of ALF."1.33Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. ( Butterworth, RF; Davies, NA; Deutz, NE; Drevland, SS; Hodges, SJ; Jalan, R; Kjønnø, M; Nedredal, GI; Prinzen, FW; Revhaug, A; Rose, C; Sen, S; Williams, R; Ytrebø, LM, 2006)
"In the experiments of BAL in vitro, acute liver failure (ALF) model in canine was induced by an end-side portocaval shunt combined with common bile duct ligation and transaction."1.33Functional evaluation of a new bioartificial liver system in vitro and in vitro. ( Chen, Z; Ding, YT, 2006)
"Latex allergy is important due to serious health impacts and widespread use of its products."1.33A latex-induced allergic airway inflammation model in mice. ( Farzaneh, P; Hassan, ZM; Hogan, SP; Hoseini, AZ; Pourpak, Z, 2006)
" Dose-response curves were constructed for the inflammatory reactions induced in nasal cavities, the smooth muscle hyperresponsiveness in the trachea, the permeability of alveolo-capillary barrier, the pulmonary vasomotricity, the cough reflex and the systemic effects."1.30[Effect of ammonia on the pig respiratory system. Study of the dose-response relation]. ( Gustin, P, 1999)
"When lactitol was given orally twice a day for 7 days at doses of 3 and 10 g/kg/day and at half that daily dose on day 8, it significantly decreased the ammonium concentration of the portal blood by 27."1.29Mechanism for lowering blood ammonia levels by lactitol. ( Hirata, Y; Kimura, K; Niida, H; Ozaki, T; Ueda, F; Watanabe, M; Yamamoto, O; Yoshikuni, Y, 1995)
"Two experimental hepatic comatose models with combined-type symptom were developed in rats."1.29[Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma]. ( Hirata, Y; Kimura, K; Ozaki, T; Watanabe, M; Yoshikuni, Y, 1995)
"Hyperammonemic encephalopathy has occasionally been reported in uremic patients receiving hyperalimentation with essential amino acid (EAA) as a source of nitrogen as one of the remaining treatment options when the enteric routes were prohibited."1.29Hyperammonemic encephalopathy due to essential amino acid hyperalimentation. ( Chang, CJ; Chen, WJ; Huang, SM; Lai, HS; Lee, JC; Wang, ST, 1994)
"Acute liver failure was induced by two-stage liver devascularization, and acute hyperammonemia by prolonged ammonia infusion such that the plasma ammonia pattern found in acute liver failure was simulated."1.29Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study. ( de Knegt, RJ; Groeneweg, M; Hekking-Weijma, I; Schalm, SW, 1994)
"The homovanillic acid content was significantly increased in the hypothalamus, hippocampus/substantia nigra and brainstem."1.29Tyrosine uptake and regional brain monoamine metabolites in a rat model resembling congenital hyperammonemia. ( Bachmann, C; Cervantes, H; Colombo, JP; Kokorovic, M; Perritaz, R, 1996)
"Lactitol and lactulose were compared in their effect on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid (CSF) in Eck fistula dogs."1.29[The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs]. ( Hirata, Y; Kimura, K; Ozaki, T; Sato, S; Suzuki, K; Watanabe, M; Yoshikuni, Y, 1995)
"Ibuprofen treatment, either solely or in combination with influenza infection, did not produce significant change in the plasma levels of aspartate or ornithine aminotransferase activities."1.28Interactions of ibuprofen with influenza infection and hyperammonemia in an animal model of Reye's syndrome. ( Deshmukh, DR; Mukhopadhyay, A; Sarnaik, AP, 1992)
"Galactosamine-induced hepatic coma is not associated with any functionally significant changes in the molecular components of the postsynaptic dopamine receptor."1.27[Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure]. ( Ferenci, P; Jones, EA; Pappas, SC; Schafer, DF, 1984)
"Effects of influenza B infection, aspirin treatment and hyperammonemia on the level of free fatty acids, total lipids and triacylglycerols in serum and liver of an animal model of Reye's syndrome are reported here."1.27Free fatty acids in an animal model of Reye's syndrome. ( Deshmukh, DR; Deshmukh, GD; Radin, NS; Shope, TC, 1983)
"Reye's syndrome is a serious childhood disorder that develops following influenza infections and is characterized in part by an encephalopathy, hyperammonemia and elevated serum transaminases."1.27Arginine deficiency, hyperammonemia and Reye's syndrome in ferrets. ( Deshmukh, DR; Thomas, PE, 1985)
"One theory of the etiology of Reye's syndrome is that environmental toxins predispose the child to react abnormally to virus infection."1.27Biochemical and morphological characteristics of a mouse model of Reye's syndrome induced by the interaction of influenza B virus and a chemical emulsifier. ( Crocker, JF; Digout, SC; Lee, SH; Malatjalian, DA; Renton, KW; Rozee, KR, 1986)
"Thus, many of the abnormalities seen in Reye's syndrome were seen in this model; however, there were no hepatic enzyme changes despite altered mitochondrial morphology and no evidence of cerebral edema despite a florid encephalopathy."1.27Investigation of an animal model of a Reye-like syndrome caused by Margosa oil. ( Arcinue, EL; Mitchell, RA; Schwartz, PH; Sinniah, D, 1985)
"Recent studies of Reye syndrome (RS) patients have suggested aspirin treatment as a possible factor in the etiology of this often fatal childhood disorder."1.26Interactions of aspirin and other potential etiologic factors in an animal model of Reye syndrome. ( Deshmukh, DR; Maassab, HF; Mason, M, 1982)
"Current theories on the pathogenesis of hepatic coma indicate that intestinal bacteria produce cerebral toxins, such as ammonia, mercaptans, and short-chain fatty acids."1.26Hyperammonemic coma after hepatectomy in germ-free rats. ( Schalm, SW; van der Mey, T, 1979)

Research

Studies (281)

TimeframeStudies, this research(%)All Research%
pre-199073 (25.98)18.7374
1990's51 (18.15)18.2507
2000's49 (17.44)29.6817
2010's87 (30.96)24.3611
2020's21 (7.47)2.80

Authors

AuthorsStudies
Kaviani, A1
Khansari Nejad, N1
Akour, A1
AlMuhaissen, SA1
Nusair, MB1
Al-Tammemi, AB1
Mahmoud, NN1
Jalouqa, S1
Alrawashdeh, MN1
Shanahan, JP1
Moore, CM1
Kampf, JW1
Szymczak, NK1
Guo, J1
Wang, H5
Luo, Y2
An, H1
Zhang, Z6
Liu, G1
Li, J15
Metcalfe, GD1
Smith, TW1
Hippler, M1
Ayala Izurieta, JE1
Márquez, CO1
García, VJ1
Jara Santillán, CA1
Sisti, JM1
Pasqualotto, N1
Van Wittenberghe, S1
Delegido, J1
Kubo, Y1
Kitagawa, Y1
Miyazaki, T1
Sohda, M1
Yamaji, T1
Sakai, M1
Saeki, H1
Nemoto, K1
Oyama, T2
Muto, M1
Takeuchi, H1
Toh, Y1
Matsubara, H1
Mano, M1
Kono, K1
Kato, K3
Yoshida, M1
Kawakubo, H1
Booka, E1
Yamatsuji, T1
Kato, H1
Ito, Y1
Ishikawa, H1
Ishihara, R1
Tsushima, T1
Kawachi, H1
Kojima, T1
Kuribayashi, S1
Makino, T1
Matsuda, S1
Doki, Y1
Ma, P1
Tang, X1
Zhang, L7
Wang, X11
Wang, W7
Zhang, X10
Wang, S3
Zhou, N1
Dodd, J1
Jordan, R1
Makhlina, M1
Pesco Koplowitz, L1
Koplowitz, B1
Barnett, K1
Yang, WH1
Spana, C1
Buchanan, SW1
Mafa-Attoye, T1
Dunfield, K1
Thevathasan, NV1
Isaac, ME1
Wu, X5
Huang, JW2
Su, BK1
Yuan, L1
Zheng, WQ1
Zhang, H6
Zheng, YX1
Zhu, W1
Chou, PT1
Manso, AP1
De Morais, DC1
Yamamoto, K1
Owen, G1
de Carvalho, RM1
Palma-Dibb, RG1
Brown, JC1
Yang, S3
Mire, EF1
Miele, L1
Ochoa, A1
Zabaleta, J1
Katzmarzyk, PT1
Moi, CT1
Bhowmick, S1
Qureshi, M1
Wang, K2
Feng, B1
Yang, Y4
Chen, Y3
Wang, Y15
Yang, L1
Jiang, K1
James, TD1
Chaturvedi, V1
Postiglione, WM1
Chakraborty, RD1
Yu, B3
Tabiś, W1
Hameed, S1
Biniskos, N1
Jacobson, A1
Zhou, H3
Greven, M1
Ferry, VE1
Leighton, C1
Wu, F2
Lei, H2
Chen, G2
Chen, C3
Song, Y2
Cao, Z1
Zhang, C5
Zhou, J1
Lu, Y2
Pappone, C1
Santinelli, V1
Mecarocci, V1
Tondi, L1
Ciconte, G1
Manguso, F1
Sturla, F1
Vicedomini, G1
Micaglio, E1
Anastasia, L1
Pica, S1
Camporeale, A1
Lombardi, M1
Shieh, PB1
Elfring, G1
Trifillis, P1
Santos, C1
Peltz, SW1
Parsons, JA1
Apkon, S1
Darras, BT1
Campbell, C1
McDonald, CM1
Galaviz, KI1
Shah, NS1
Gutierrez, M1
Collins, LF1
Lahiri, CD1
Moran, CA1
Szabo, B1
Sumitani, J1
Rhodes, J1
Marconi, VC1
Nguyen, ML1
Cantos, VD1
Armstrong, WS1
Colasanti, JA1
Mao, X1
Chen, H2
Lin, AZ1
Kim, S1
Burczynski, ME1
Na, E1
Halasz, G1
Sleeman, MW1
Murphy, AJ1
Okamoto, H1
Cheng, X2
Macedo de Oliveira, M1
Monnet-Aimard, A1
Bosoi, CR5
Tremblay, M6
Rose, CF7
Soria, LR2
Makris, G3
D'Alessio, AM1
De Angelis, A2
Boffa, I1
Pravata, VM1
Rüfenacht, V1
Attanasio, S2
Nusco, E1
Arena, P1
Ferenbach, AT1
Paris, D1
Cuomo, P1
Motta, A1
Nitzahn, M3
Lipshutz, GS6
Martínez-Pizarro, A1
Richard, E1
Desviat, LR1
Häberle, J5
van Aalten, DMF1
Brunetti-Pierri, N2
Belanger, AJ1
Gefteas, E1
Przybylska, M1
Geller, S1
Anarat-Cappillino, G1
Kloss, A1
Yew, NS1
Claeys, W1
Van Hoecke, L1
Geerts, A1
Van Vlierberghe, H1
Lefere, S1
Van Imschoot, G1
Van Wonterghem, E1
Ghesquière, B1
Vandenbroucke, RE1
Van Steenkiste, C1
Qutob, HMH1
Saad, RA1
Bali, H1
Osailan, A1
Jaber, J1
Alzahrani, E1
Alyami, J1
Elsayed, H1
Alserihi, R1
Shaikhomar, OA1
Divya, KM1
Savitha, DP1
Krishna, GA1
Dhanya, TM1
Mohanan, PV1
Shah, SF1
Jafry, AT1
Hussain, G1
Kazim, AH1
Ali, M1
Rivani, E1
Endraswari, PD1
Widodo, ADW1
Khalil, MR1
Guldberg, R1
Nørgård, BM1
Uldbjerg, N1
Wehberg, S1
Fowobaje, KR1
Mashood, LO1
Ekholuenetale, M1
Ibidoja, OJ1
Romagnoli, A1
D'Agostino, M1
Pavoni, E1
Ardiccioni, C1
Motta, S1
Crippa, P1
Biagetti, G1
Notarstefano, V1
Rexha, J1
Perta, N1
Barocci, S1
Costabile, BK1
Colasurdo, G1
Caucci, S1
Mencarelli, D1
Turchetti, C1
Farina, M1
Pierantoni, L1
La Teana, A1
Al Hadi, R1
Cicconardi, F1
Chinappi, M1
Trucchi, E1
Mancia, F1
Menzo, S1
Morozzo Della Rocca, B1
D'Annessa, I1
Di Marino, D1
Choya, A1
de Rivas, B1
Gutiérrez-Ortiz, JI1
López-Fonseca, R1
Xu, S1
Cheng, B1
Huang, Z3
Liu, T3
Li, Y11
Jiang, L2
Guo, W2
Xiong, J1
Amirazodi, M1
Daryanoosh, F1
Mehrabi, A1
Gaeini, A1
Koushkie Jahromi, M1
Salesi, M1
Zarifkar, AH1
Studeny, P1
Netukova, M1
Nemcokova, M1
Klimesova, YM1
Krizova, D1
Kang, H1
Tao, Y1
Zhang, Q6
Sha, D1
Yao, J1
Gao, Y5
Liu, J8
Ji, L1
Shi, P1
Shi, C1
Wu, YL1
Wright, AI1
M El-Metwaly, N1
A Katouah, H1
El-Desouky, MG1
El-Bindary, AA1
El-Bindary, MA1
Kostakis, ID1
Raptis, DA1
Davidson, BR1
Iype, S1
Nasralla, D1
Imber, C1
Sharma, D1
Pissanou, T1
Pollok, JM1
Hughes, AM1
Sanderson, E1
Morris, T1
Ayorech, Z1
Tesli, M1
Ask, H1
Reichborn-Kjennerud, T1
Andreassen, OA1
Magnus, P1
Helgeland, Ø1
Johansson, S1
Njølstad, P1
Davey Smith, G1
Havdahl, A1
Howe, LD1
Davies, NM1
Amrillah, T1
Prasetio, A1
Supandi, AR1
Sidiq, DH1
Putra, FS1
Nugroho, MA1
Salsabilla, Z1
Azmi, R1
Grammatikopoulos, P1
Bouloumis, T1
Steinhauer, S1
Mironov, VS2
Bazhenova, TA2
Manakin, YV2
Yagubskii, EB2
Yakushev, IA1
Gilmutdinov, IF1
Simonov, SV1
Lan, K1
Yang, H1
Zheng, J2
Hu, H2
Zhu, T1
Zou, X1
Hu, B2
Liu, H5
Olokede, O1
Wu, H1
Holtzapple, M1
Gungor, O1
Kose, M1
Ghaemi, R1
Acker, M1
Stosic, A1
Jacobs, R1
Selvaganapathy, PR1
Ludwig, N1
Yerneni, SS1
Azambuja, JH1
Pietrowska, M1
Widłak, P1
Hinck, CS1
Głuszko, A1
Szczepański, MJ1
Kärmer, T1
Kallinger, I1
Schulz, D1
Bauer, RJ1
Spanier, G1
Spoerl, S1
Meier, JK1
Ettl, T1
Razzo, BM1
Reichert, TE1
Hinck, AP1
Whiteside, TL1
Wei, ZL1
Juan, W1
Tong, D1
Juan, LX1
Sa, LY1
Jie, HFM1
Xiao, G1
Xiang, LG1
Jie, HM1
Xu, C3
Yu, DN1
Yao, ZX1
Bigdeli, F1
Gao, XM1
Li, JZ1
Zhang, JW1
Guan, ZJ1
Bu, Y1
Liu, KG1
Morsali, A1
Das, R1
Paul, R1
Parui, A1
Shrotri, A1
Atzori, C1
Lomachenko, KA1
Singh, AK1
Mondal, J1
Peter, SC1
Florimbio, AR1
Coughlin, LN1
Bauermeister, JA1
Young, SD1
Zimmerman, MA1
Walton, MA1
Bonar, EE1
Demir, D1
Balci, AB1
Kahraman, N1
Sunbul, SA1
Gucu, A1
Seker, IB1
Badem, S1
Yuksel, A1
Ozyazicioglu, AF1
Goncu, MT1
Deng, Z3
Luo, L2
Ong, SP1
Wang, C4
Xin, H1
Whittingham, MS1
Zhou, G1
Maemura, R1
Wakamatsu, M1
Matsumoto, K1
Sakaguchi, H1
Yoshida, N1
Hama, A1
Yoshida, T1
Miwata, S1
Kitazawa, H1
Narita, K1
Kataoka, S1
Ichikawa, D1
Hamada, M1
Taniguchi, R1
Suzuki, K3
Kawashima, N1
Nishikawa, E1
Narita, A1
Okuno, Y1
Nishio, N1
Kojima, S1
Morita, K1
Muramatsu, H1
Takahashi, Y1
Yirgu, A1
Mekonnen, Y1
Eyado, A1
Staropoli, A1
Vinale, F1
Zac, J1
Zac, S1
Pérez-Padilla, R1
Remigio-Luna, A1
Guzmán-Boulloud, N1
Gochicoa-Rangel, L1
Guzmán-Valderrábano, C1
Thirión-Romero, I1
Statsenko, ME1
Turkina, SV1
Barantsevich, ER1
Karakulova, YV1
Baranova, NS1
Morzhukhina, MV1
Wang, Q4
Gu, Y1
Qiao, L2
Pan, F1
Song, C1
Canetto, SS1
Entilli, L1
Cerbo, I1
Cipolletta, S1
Wu, Y4
Zhu, P1
Jiang, Y2
Wang, Z6
Xie, B1
Song, T1
Zhang, F1
Luo, A1
Li, S4
Xiong, X2
Han, J3
Peng, X2
Li, M1
Huang, L3
Chen, Q2
Fang, W1
Hou, Y1
Zhu, Y2
Ye, J2
Liu, L1
Islam, MR1
Sanderson, P1
Johansen, MP1
Payne, TE1
Naidu, R1
Cao, J1
Yang, J4
Niu, X1
Liu, X5
Zhai, Y1
Qiang, C1
Niu, Y1
Li, Z5
Dong, N1
Wen, B1
Ouyang, Z1
Zhang, Y10
Zhao, M2
Zhao, J1
Morici, P1
Rizzato, C1
Ghelardi, E1
Rossolini, GM1
Lupetti, A1
Gözüküçük, R1
Cakiroglu, B1
He, X2
Li, R1
Zhao, D3
Ji, X1
Fan, X1
Chen, J3
Zheng, D1
Xie, L1
Sun, S1
Cai, Z1
Liu, Q3
Ma, K1
Sun, X2
Drinkwater, JJ1
Davis, TME1
Turner, AW1
Davis, WA1
Suzuki, Y1
Mizuta, Y1
Mikagi, A1
Misawa-Suzuki, T1
Tsuchido, Y1
Sugaya, T1
Hashimoto, T1
Ema, K1
Hayashita, T1
Zhou, C3
Fu, Y1
Liu, S3
Cai, L3
Jiang, Z2
Xu, X2
Feng, L3
Vong, LB1
Ibayashi, Y1
Lee, Y1
Ngo, DN1
Nishikawa, Y1
Nagasaki, Y1
Bobenko, AI1
Heller, S1
Schmitt, N1
Cherdtrakulkiat, R1
Lawung, R1
Nabu, S1
Tantimavanich, S1
Sinthupoom, N1
Prachayasittikul, S1
Prachayasittikul, V1
Zhang, B2
Wu, C2
Yan, K1
Li, C4
Li, L7
Zheng, C1
Xiao, Y1
He, D1
Zhao, F1
Su, JF1
Lun, SM1
Hou, YJ1
Duan, LJ1
Wang, NC1
Shen, FF1
Zhang, YW2
Gao, ZW1
Du, XJ1
Zhou, FY1
Yin, Z2
Zhu, J4
Yan, D1
Lou, H1
Yu, H4
Feng, C1
Hu, X1
Shen, Y2
Hu, D2
Duan, Y1
Zhi, D1
Zou, M2
Zhao, Z1
Yang, X5
Zhang, J5
Popović, KJ1
Popović, DJ1
Miljković, D1
Lalošević, D1
Čapo, I1
Popović, JK1
Liu, M3
Song, H2
Xing, Z1
Lu, G1
Chen, D6
Valentini, AM1
Di Pinto, F1
Coletta, S1
Guerra, V1
Armentano, R1
Caruso, ML1
Gong, J1
Wang, N1
Bian, L1
Wang, M1
Ye, M2
Wen, N1
Fu, M1
Fan, W1
Meng, Y1
Dong, G1
Lin, XH1
Liu, HH1
Gao, DM1
Cui, JF1
Ren, ZG1
Chen, RX1
Önal, B1
Özen, D1
Demir, B1
Akkan, AG1
Özyazgan, S1
Payette, G1
Geoffroy, V1
Martineau, C1
Villemur, R1
Jameel, T1
Baig, M1
Gazzaz, ZJ2
Tashkandi, JM1
Al Alhareth, NS1
Khan, SA1
Butt, NS1
Wang, J9
Geng, Y1
Basit, A1
Miao, T1
Liu, W3
Jiang, W4
Yu, ZY1
Wu, L2
Qu, B1
Sun, JX1
Cai, AL1
Xie, LM1
Groeneveld, J1
Ho, SL1
Mackensen, A1
Mohtadi, M1
Laepple, T1
Genovesi, S1
Nava, E1
Bartolucci, C1
Severi, S1
Vincenti, A1
Contaldo, G1
Bigatti, G1
Ciurlino, D1
Bertoli, SV1
Slovak, JE1
Hwang, JK1
Rivera, SM1
Villarino, NF1
Cao, G1
Ling, M1
Ji, J1
Sha, Y1
Gao, X1
Liang, C3
Guo, Q2
Ma, Z1
Xu, J3
Zhao, W3
Xia, X1
Peng, J1
Jia, Z1
Li, F1
Chen, X6
Mo, J1
Zhang, S4
Li, X5
Huang, T1
Zhu, Q1
Ge, RS1
Fortunato, G1
Lin, J2
Agarwal, PK1
Kohen, A1
Singh, P1
Cheatum, CM1
Zhu, D1
Hayman, A1
Kebede, B1
Stewart, I1
Frew, R1
Guo, X1
Gong, Q1
Borowiec, J1
Han, S2
Zhang, M3
Willis, M1
Kreouzis, T1
Yu, K1
Chirvony, VS1
Sekerbayev, KS1
Pérez-Del-Rey, D1
Martínez-Pastor, JP1
Palazon, F1
Boix, PP1
Taurbayev, TI1
Sessolo, M1
Bolink, HJ1
Lu, M3
Lan, Y1
Xiao, J1
Song, M2
Huang, Q1
Cao, Y1
Ho, CT1
Qi, B1
Zhang, W2
Fang, L1
Xie, CL1
Chen, R1
Xia, JM1
Zhang, GY1
Chen, CH1
Yang, XW1
Domenech-Ximenos, B1
Garza, MS1
Prat-González, S1
Sepúlveda-Martínez, Á1
Crispi, F1
Perea, RJ1
Garcia-Alvarez, A1
Sitges, M1
Kalumpha, M1
Guyo, U1
Zinyama, NP1
Vakira, FM1
Nyamunda, BC1
Varga, M1
Drácz, L1
Kolbenheyer, E1
Varga, F1
Patai, ÁV1
Solymosi, N1
Patai, Á1
Kiss, J1
Gaál, V1
Nyul, Z1
Mosdósi, B1
Valdez, M1
Moosavi, L1
Heidari, A1
Novakovic-Agopian, T1
Kornblith, E1
Abrams, G1
McQuaid, JR1
Posecion, L1
Burciaga, J1
D'Esposito, M1
Chen, AJW1
Samy El Gendy, NM1
Wesolowska, P1
Georg, D1
Lechner, W1
Kazantsev, P1
Bokulic, T1
Tedgren, AC1
Adolfsson, E1
Campos, AM1
Alves, VGL1
Suming, L1
Hao, W1
Ekendahl, D1
Koniarova, I1
Bulski, W1
Chelminski, K1
Samper, JLA1
Vinatha, SP1
Rakshit, S1
Siri, S1
Tomsejm, M1
Tenhunen, M1
Povall, J1
Kry, SF1
Followill, DS1
Thwaites, DI1
Izewska, J1
Kang, JH1
Yoon, Y1
Song, J2
Van de Winckel, A1
Gauthier, L1
Chao, CT1
Lee, YH1
Li, CM1
Han, DS1
Huang, KC1
Ni, L2
Güttinger, R1
Triana, CA1
Spingler, B1
Baldridge, KK1
Patzke, GR1
Shen, X1
Wang, B5
Xie, S1
Deng, W1
Wu, D1
Voskamp, BJ1
Peelen, MJCS1
Ravelli, ACJ1
van der Lee, R1
Mol, BWJ1
Pajkrt, E1
Ganzevoort, W1
Kazemier, BM1
Tibrewala, R1
Bahroos, E1
Mehrabian, H1
Foreman, SC1
Link, TM1
Pedoia, V1
Majumdar, S1
Jablonski, CL1
Leonard, C1
Salo, P1
Krawetz, RJ1
Yoon, N1
Hong, SN1
Cho, JG1
Jeong, HK1
Lee, KH1
Park, HW1
Barman, S1
Konai, MM1
Samaddar, S1
Haldar, J1
Mohamed, HSH1
Li, CF1
Hu, ZY1
Chen, LH1
Su, BL1
Chu, K1
Liu, YP1
Li, YB1
Zou, Z3
Wu, Z1
Xia, Y2
Zhao, P1
Wang, HT1
de Biase, S1
Pellitteri, G1
Gigli, GL1
Valente, M1
Truong, B2
Allegri, G4
Liu, XB3
Burke, KE1
Zhu, X2
Cederbaum, SD3
Martini, PGV1
Lu, L1
Lu, BJ1
Xie, D2
Bahaji Azami, NL1
An, YT1
Wang, HJ1
Ye, G1
Sun, MY1
Tran, HTN1
Saber, YH1
Hall, FS1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Hu, K1
Guo, Z1
Huang, H5
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Zang, YP2
Niu, LL2
Fu, YJ3
Yao, LP1
Qin, QP1
Wang, ZY1
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Jiang, H1
He, C2
Xiao, Z1
Sun, Q2
Han, D1
Zhao, K2
Zhu, L1
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z4
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Xu, N1
Wang, R1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Chen, L3
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H5
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Gilson, E1
Yan, R1
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S2
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
An, Z1
Jiang, J2
Du, S1
Cui, J1
Wu, W1
Liu, Y7
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W2
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J3
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L2
Wang, L4
Hu, T1
Wang, F2
Han, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Luo, X1
Dai, T1
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Du, Q1
Hao, P1
Cao, X1
Li, CX2
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Xie, Y2
Tang, J3
Chen, Z4
Luo, W1
Xiong, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Qiu, N1
Yin, J1
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S2
Duan, W1
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Yang, Z3
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Quan, M1
Dong, J2
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Liu, C2
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Cao, Q2
Yuan, X1
Nie, W1
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X2
Pang, B1
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Ou, Y1
Huang, M1
Yu, J1
Tian, J1
Hu, J1
Yao, C2
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W2
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ2
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Kawazoe, Y1
Jena, P1
Sun, Z1
Liang, H1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P2
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Ruan, Z1
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Chen, S1
Luo, M1
Wu, J2
Cai, S1
He, Y3
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S2
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H2
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Liang, J1
Hu, BC1
Wen, Z1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X2
Wang, D2
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Khoja, S2
Zheng, DW1
Pan, P1
Chen, KW1
Fan, JX1
Zhang, XZ1
Xu, M1
Hu, TY1
Li, DC1
Fan, JT1
Fan, XM1
Zeng, XH1
Qiu, SQ1
Cheng, BH1
Vincenzi, KL1
Maia, TP1
Delmônego, L1
Lima, AB1
Pscheidt, LC1
Delwing-Dal Magro, D1
Delwing-de Lima, D1
Sugahara, G1
Yamasaki, C1
Yanagi, A1
Furukawa, S1
Ogawa, Y1
Fukuda, A1
Enosawa, S2
Umezawa, A1
Ishida, Y1
Tateno, C1
Clément, MA1
Oliveira, MM2
Bémeur, C3
Mikkelsen, ACD1
Thomsen, KL3
Vilstrup, H4
Aamann, L2
Jones, H2
Mookerjee, RP3
Hamilton-Dutoit, S1
Frystyk, J1
Aagaard, NK2
Zabulica, M1
Srinivasan, RC1
Akcakaya, P1
Bestas, B1
Firth, M1
Hammarstedt, C1
Jakobsson, T2
Ellis, E1
Jorns, C1
Scherer, T2
Rimann, N2
van Zuydam, NR1
Gramignoli, R1
Forslöw, A1
Engberg, S1
Maresca, M1
Rooyackers, O1
Thöny, B3
Rosen, B1
Strom, SC1
Trigun, SK1
Fenn, S1
Dubern, JF1
Cigana, C1
De Simone, M1
Lazenby, J1
Juhas, M1
Schwager, S1
Bianconi, I1
Döring, G1
Elmsley, J1
Eberl, L1
Williams, P1
Bragonzi, A1
Cámara, M1
Ji, CX1
Mei, LH1
Qiang, JW1
Ju, S1
Mansour, SZ1
El-Marakby, SM1
Moawed, FSM1
Galland, F1
Negri, E1
Da Ré, C1
Fróes, F1
Strapazzon, L1
Guerra, MC1
Tortorelli, LS1
Gonçalves, CA1
Leite, MC1
He, GL2
Zhou, CJ1
Cheng, Y1
Jiang, ZS2
Pan, MX2
Mendes, NF2
Mariotti, FFN1
de Andrade, JS1
de Barros Viana, M1
Céspedes, IC2
Nagaoka, MR2
Le Sueur-Maluf, L2
Murad, HA1
Ali, SS1
Ibraheem, MS1
Lai, Y1
Dong, L1
Weng, J1
Peng, Q1
Kuang, Y1
Li, B1
Fan, J1
Qiao, X1
Lkhagva, E1
Chung, HJ1
Kim, HJ1
Hong, ST1
De Chiara, F3
Rombouts, K2
Andreola, F2
Jalan, R9
Wilson, KD1
Ochoa, LF1
Solomon, OD1
Pal, R1
Cardona, SM1
Carpio, VH1
Keiser, PH1
Cardona, AE1
Vargas, G1
Stephens, R1
Gabbi, P1
Nogueira, V1
Haupental, F1
Rodrigues, FS1
do Nascimento, PS1
Barbosa, S1
Arend, J1
Furian, AF1
Oliveira, MS1
Dos Santos, ARS1
Royes, LFF1
Fighera, MR1
Lu, H1
Liu, P2
Xie, G1
Jiang, R1
Zhao, A1
Yan, J1
Zheng, X1
Huang, F1
Panee, J1
Rajani, C1
Jia, W2
Sun, B1
Jung, E1
Kim, J1
Ochoa-Sanchez, R2
Oliveira, M1
Dam, G1
Kurtz, CB1
Millet, YA1
Puurunen, MK1
Perreault, M1
Charbonneau, MR1
Isabella, VM1
Kotula, JW1
Antipov, E1
Dagon, Y1
Denney, WS1
Wagner, DA1
West, KA1
Degar, AJ1
Brennan, AM1
Miller, PF1
Deplazes, S1
Causton, B1
Leff, JW1
Diez-Fernandez, C1
Klimovskaia, A1
Fingerhut, R2
Krijt, J1
Kožich, V1
Nuoffer, JM1
Grisch-Chan, HM1
Annunziata, P1
Palmer, DJ1
Ng, P1
Qvartskhava, N1
Jin, CJ1
Buschmann, T1
Albrecht, U1
Bode, JG1
Monhasery, N1
Oenarto, J1
Bidmon, HJ2
Görg, B2
Häussinger, D3
Saheki, T4
Moriyama, M2
Kuroda, E1
Funahashi, A1
Yasuda, I1
Setogawa, Y1
Gao, Q1
Ushikai, M1
Furuie, S1
Yamamura, KI1
Takano, K1
Nakamura, Y1
Eto, K2
Kadowaki, T2
Sinasac, DS3
Furukawa, T1
Horiuchi, M2
Tai, YH1
Souza Morini, F1
de Castro, E1
de Morais, SB1
Lancheros Contreras, C1
Pereira Weiler, AV1
Murakami, MT1
Pinge-Filho, P1
Yamada-Ogatta, SF1
de Arruda Campos Brasil de Souza, T1
Habtesion, A2
Davies, N3
Gracia-Sancho, J1
Manicardi, N1
Hall, A1
Paish, HL1
Reed, LH1
Watson, AA1
Leslie, J1
Oakley, F1
Mann, J1
Al-Chalabi, A1
Matevossian, E1
V Thaden, AK1
Luppa, P1
Neiss, A1
Schuster, T1
Schreiber, C1
Schimmel, P1
Nairz, E1
Perren, A1
Radermacher, P1
Huber, W1
Schmid, RM1
Kreymann, B1
Holecek, M2
Chastre, A1
Bélanger, M2
Nguyen, BN1
Butterworth, RF5
Chandler, RJ1
Tarasenko, TN1
Cusmano-Ozog, K1
Sutton, VR1
Venditti, CP1
McGuire, PJ1
Jayakumar, AR2
Tong, XY1
Curtis, KM1
Ruiz-Cordero, R1
Abreu, MT1
Norenberg, MD6
Loureiro, I1
Faria, J1
Clayton, C1
Ribeiro, SM1
Roy, N1
Santarém, N1
Tavares, J1
Cordeiro-da-Silva, A1
Jover-Cobos, M1
Noiret, L1
Lee, K1
Sharma, V1
Romero-Gomez, M2
Kosenko, EA1
Tikhonova, LA1
Reddy, VP2
Aliev, G1
Kaminsky, YG1
Juárez-Orozco, LE1
Szymanski, MK1
Hillege, HL1
Kruizinga, S1
Noordzij, W1
Koole, M1
Tio, RA1
Alexanderson, E1
Dierckx, RA1
Slart, RH1
Kristiansen, RG1
Fuskevåg, OM1
Mæhre, H1
Revhaug, A3
Ytrebø, LM3
Hu, C1
Tai, DS1
Park, H1
Cantero, G2
Cantero-Nieto, G1
Chan, E1
Yudkoff, M4
Bürki, R1
Mohebbi, N1
Bettoni, C1
Serra, AL1
Wagner, CA1
Zhang, CL1
Duan, ZJ1
Tian, G1
Tian, Y1
He, GH1
Bian, TF1
Sun, XY1
Chang, QY1
Lautamaki, R2
Sasano, T3
Higuchi, T1
Nekolla, SG3
Lardo, AC3
Holt, DP2
Dannals, RF2
Abraham, MR2
Bengel, FM3
Marozkina, NV1
Gaston, B1
Daly, KP1
Dearling, JL1
Seto, T1
Dunning, P1
Fahey, F1
Packard, AB1
Briscoe, DM1
Viana, MB1
Amorim, AL1
Cardoso, AN1
Rodrigues, BC1
Bittencourt, JC1
Grimm, PR1
Lazo-Fernandez, Y1
Delpire, E1
Wall, SM2
Dorsey, SG1
Weinman, EJ1
Coleman, R1
Wade, JB1
Welling, PA1
Saracyn, M3
Zdanowski, R1
Brytan, M1
Kade, G1
Nowak, Z2
Patera, J2
Dyrla, P1
Gil, J1
Wańkowicz, Z2
Shen, TC1
Albenberg, L1
Bittinger, K1
Chehoud, C1
Chen, YY1
Judge, CA1
Chau, L1
Ni, J1
Sheng, M1
Lin, A1
Wilkins, BJ1
Buza, EL1
Lewis, JD1
Daikhin, Y1
Nissim, I1
Bushman, FD1
Wu, GD1
Wu, QZ1
Zhao, DX1
Xiang, J1
Zhang, CF1
Xu, XH1
Mladenović, D1
Hrnčić, D1
Rašić-Marković, A1
Macut, Dj1
Stanojlović, O1
Northrop, NA1
Halpin, LE2
Yamamoto, BK2
Tamaoki, S1
Suzuki, H2
Okada, M1
Fukui, N1
Isobe, M1
Saito, T2
Cittolin-Santos, GF1
de Assis, AM1
Guazzelli, PA1
Paniz, LG1
da Silva, JS1
Calcagnotto, ME1
Hansel, G1
Zenki, KC1
Kalinine, E1
Duarte, MM1
Souza, DO1
Mervis, RF1
Lazaro, MT1
Golshani, P1
Qi, QQ1
Chen, FX1
Zhao, DY1
Li, LX1
Li, YQ1
Zuo, XL1
Qamar, TR1
Syed, F1
Nasir, M1
Rehman, H1
Zahid, MN1
Liu, RH1
Iqbal, S1
Forny, P1
Schumann, A1
Mustedanagic, M1
Mathis, D1
Wulf, MA1
Nägele, N1
Langhans, CD1
Zhakupova, A1
Heeren, J1
Scheja, L1
Peters, HL1
Hornemann, T1
Kölker, S1
Burda, P1
Froese, DS1
Devuyst, O1
Baumgartner, MR1
Karau, MJ1
Greenwood-Quaintance, KE1
Block, DR1
Mandrekar, JN1
Cunningham, SA1
Patel, R1
Shapiro, LA1
Cotrina, ML1
Wang, EW1
Nedergaard, M1
Huang, JH1
Ten Have, GA1
Deutz, NE3
Hadjihambi, A1
Hosford, PS1
Habtetion, A1
Karagiannis, A1
Gourine, AV1
Popek, M1
Bobula, B1
Sowa, J1
Hess, G1
Polowy, R1
Filipkowski, RK1
Frontczak-Baniewicz, M1
Zabłocka, B1
Albrecht, J2
Zielińska, M1
Kumar, A1
Davuluri, G1
Silva, RNE1
Engelen, MPKJ1
Ten Have, GAM1
Prayson, R1
Deutz, NEP1
Dasarathy, S1
Chang, KC1
Ashikaga, H1
Mills, KJ1
Hilton, J1
Halperin, H1
Marbán, E1
Cauli, O3
Rodrigo, R3
Boix, J2
Piedrafita, B1
Agusti, A2
Felipo, V5
Banas, A1
Teratani, T1
Yamamoto, Y1
Tokuhara, M1
Takeshita, F1
Osaki, M1
Kato, T1
Okochi, H1
Ochiya, T1
Wesołowski, P1
Kozłowski, W2
Shawcross, DL2
Wright, GA1
Stadlbauer, V2
Hodges, SJ3
Davies, NA4
Wheeler-Jones, C1
Pitsillides, AA1
Nicaise, C1
Prozzi, D1
Viaene, E1
Moreno, C1
Gustot, T1
Quertinmont, E1
Demetter, P1
Suain, V1
Goffin, P1
Devière, J1
Hols, P1
Takahashi, K1
Umehara, Y1
Umehara, M1
Nishimura, A1
Narumi, S1
Toyoki, Y1
Hakamada, K1
Yoshihara, S1
Sasaki, M1
Bak, LK1
Iversen, P1
Sørensen, M1
Keiding, S1
Ott, P1
Waagepetersen, HS1
Schousboe, A1
Holz, A1
Merrill, J1
Desjardins, P1
Chen, YR1
Sekine, K1
Nakamura, K1
Yanai, H1
Tanaka, M1
Miyajima, A1
Gura, V1
Macy, AS1
Beizai, M1
Ezon, C1
Golper, TA1
Kaminsky, Y1
Kosenko, E1
Hakvoort, TB2
Vermeulen, JL1
Labruyère, WT1
De Waart, DR1
Van Der Hel, WS1
Ruijter, JM1
Uylings, HB1
Lamers, WH1
Lee, HW1
Verlander, JW1
Bishop, JM1
Nelson, RD1
Handlogten, ME1
Weiner, ID1
Teixeira, AR1
Machado, MC1
Kubrusly, MS1
Molan, NT1
Bellodi-Privato, M1
Leite, KR1
D'Albuquerque, LA1
Kandar, R1
Sispera, L1
Kovarik, M1
Aires, CC1
van Cruchten, A1
Ijlst, L1
de Almeida, IT1
Duran, M1
Wanders, RJ1
Silva, MF1
Mahmoud, AM1
Zemtsova, I1
Keitel, V1
Schrör, K1
Frühauf, NR1
Radunz, S1
Grabellus, F1
Laube, T1
Uerschels, AK1
Kaiser, GM1
Llansola, M2
Hernández-Rabaza, V1
Arkadopoulos, N1
Defterevos, G1
Nastos, C1
Papalois, A1
Kalimeris, K1
Papoutsidakis, N1
Kampouroglou, G1
Kypriotis, D1
Pafiti, A1
Kostopanagiotou, G1
Smyrniotis, V1
Oria, M1
Romero-Giménez, J1
Arranz, JA1
Riudor, E1
Raguer, N1
Córdoba, J1
Inoue, K1
Ono, H1
Tushima, A1
Katsura, N2
Yokogawa, M1
Yoshidumi, Y1
Kuhara, T1
Ohse, M1
Kobayashi, K2
Yeh, TH1
Singh, VP1
Shiva, S1
Krauland, L1
Zhang, P1
Kharbanda, K1
Ritov, V1
Monga, SP1
Scott, DK1
Eagon, PK1
Behari, J1
Brunelli, L1
Campagna, R1
Airoldi, L1
Pastorelli, R1
Back, A1
Tupper, KY1
Bai, T1
Chiranand, P1
Goldenberg, FD1
Frank, JI1
Brorson, JR1
Li, ZY1
Zhi, HJ1
Xue, SY1
Sun, HF1
Zhang, FS1
Jia, JP1
Xing, J1
Zhang, LZ1
Qin, XM1
Huynh, J1
Parent-Robitaille, C1
Ryska, O1
Pantoflicek, T1
Laszikova, E1
Prazak, J1
Koblihova, E1
Ryska, M1
Carpéné, C1
Desquesnes, A1
Gomez-Ruiz, A1
Iffiú-Soltész, Z1
Le Gonidec, S1
Mercader, J1
Viegas, CM1
Busanello, EN1
Tonin, AM1
Grings, M1
Moura, AP1
Ritter, L1
Zanatta, A1
Knebel, LA1
Lobato, VA1
Pettenuzzo, LF1
Vargas, CR1
Leipnitz, G1
Wajner, M1
Nibourg, GA1
Hoekstra, R1
van der Hoeven, TV1
Ackermans, MT1
van Gulik, TM1
Chamuleau, RA4
Nagahashi, S1
Miyazawa, M1
Nagata, H1
Suzuki, M1
Miura, S1
Ishii, H1
Ding, YT2
Qiu, YD1
Xu, QX1
Zhang, HY1
Tang, Q1
Yu, DC1
Yildiz, H1
Oncel, M1
Kurt, N1
Vural, S1
Gezen, C1
Dalkilic, G1
Olcay, E1
Noguchi, K1
Dairaku, N1
Koike, T1
Iijima, K1
Imatani, A1
Sekine, H1
Ohara, S1
Sasano, H1
Shimosegawa, T1
Jalil, MA1
Begum, L1
Li, MX1
Iijima, M1
Robinson, BH1
Tsui, LC1
Kuhrt, H1
Walski, M1
Reichenbach, A1
Shindoh, J1
Naruse, K1
Sakai, Y1
Makuuchi, M1
Bury-Moné, S1
Thiberge, JM1
Contreras, M1
Maitournam, A1
Labigne, A1
De Reuse, H1
Xiang, Z2
Si, JM1
Huang, HD1
Wańikowicz, Z1
Alexander, B1
Smart, KA1
Segal, MB1
Preston, JE1
Lee, KU1
Zheng, LX1
Cho, YB1
Kim, KH1
Ha, J1
Suh, KS1
Jung, SE1
Sen, S2
Rose, C2
Nedredal, GI2
Drevland, SS1
Kjønnø, M1
Prinzen, FW1
Williams, R3
Gambaro, G1
Jover, M1
Diaz-Gomez, D1
de Teran, LC1
Camacho, I1
Echevarria, M1
Bautista, JD1
Farzaneh, P1
Hassan, ZM1
Pourpak, Z1
Hoseini, AZ1
Hogan, SP1
Harputluoglu, MM1
Demirel, U1
Ciralik, H1
Temel, I1
Firat, S1
Ara, C1
Aladag, M1
Karincaoglu, M1
Hilmioglu, F1
Wright, G1
Zwingmann, C1
Brooks, HF1
Mani, AR1
Harry, D1
Davies, C1
Moore, KP1
Huang, HC1
Wang, SS1
Lee, FY1
Chan, CY1
Chang, FY1
Lin, HC1
Chu, CJ1
Chen, YC1
Lee, SD1
Marini, JC1
Erez, A1
Castillo, L1
Lee, B2
Dethloff, TJ1
Knudsen, GM1
Larsen, FS1
Lichter-Konecki, U1
Mangin, JM1
Gordish-Dressman, H1
Hoffman, EP1
Gallo, V1
Nagami, GT1
Jones, EA5
Ferenci, P2
Pappas, SC2
Schafer, DF2
Rarey, KE1
Rush, NL1
Davis, JA1
Deshmukh, DR6
de Groot, GH2
Schalm, SW6
Schicht, I1
Batavier, P1
de Jonge, M1
Lens, J1
Terpstra, JL1
Deshmukh, GD1
Shope, TC1
Radin, NS1
Awrich, P1
Madge, GE1
Wolf, B1
Bachmann, C2
Colombo, JP2
Gerok, W1
Imler, M1
Schlienger, JL1
Chabrier, G1
Comte, F1
Glasgow, AM1
Pilbeam, CM2
Anderson, RM2
Bhathal, PS2
Spector, EB1
Mazzocchi, RA1
Maassab, HF2
Mason, M2
Kao, W1
Baublis, JV1
Higashi, T1
Matkowitz, R1
Hartig, W1
Haupt, R1
Börner, P1
Weiner, R1
Wagner, G1
Bergqvist, PB1
Vogels, BA2
Bosman, DK1
Maas, MA2
Hjorth, S1
Bengtsson, F2
Watanabe, M3
Ozaki, T3
Hirata, Y3
Yoshikuni, Y3
Kimura, K3
Sato, S2
Yamamoto, O1
Niida, H1
Ueda, F1
Mullen, KD5
Birgisson, S1
Gacad, RC1
Conjeevaram, H1
Lee, JC1
Lai, HS1
Huang, SM1
Chang, CJ1
Wang, ST1
Chen, WJ1
Momo, K1
Hoshina, K1
Ishibashi, Y1
Aquilio, E1
Spagnoli, R1
Riggio, D1
Seri, S1
Rao, VL1
Qureshi, IA5
Conjeevaram, HS2
Nagle, A1
Katz, A1
Kaminsky-Russ, K1
McCullough, AJ2
de Knegt, RJ1
Groeneweg, M1
Hekking-Weijma, I1
Patejunas, G2
Bradley, A1
Beaudet, AL2
O'Brien, WE2
May, EJ1
Ratnakumari, L1
Michalak, A1
Dial, EJ1
Hall, LR1
Romero, JJ1
Lichtenberger, LM1
Prakash, S1
Chang, TM1
Cervantes, H1
Kokorovic, M1
Perritaz, R1
Batshaw, ML4
McLaughlin, BA2
Gorry, E2
Anegawa, NJ2
Smith, IA1
Hyman, SL2
Robinson, MB3
Guinjoan, SM1
Yannielli, PC1
Lococco, J1
Siri, LN1
Cardinali, DP1
Hopkins, K1
Heyes, MP2
Oster-Granite, ML1
Itzhak, Y1
Roig-Cantisano, A1
Dombro, RS1
Hawkins, PA1
DeJoseph, MR1
Viña, JR1
Hawkins, RA1
Wrong, O1
Roessle, M1
Jones, DB1
Grun, M1
Daalhuisen, J1
Quack, G1
Watanabe, A1
Tsuchida, T1
Kuwabara, Y1
Rao, KV1
Skarpetas, A1
Mawal, Y1
Eguchi, S1
Lilja, H1
Hewitt, WR1
Middleton, Y1
Demetriou, AA1
Rozga, J1
Sheil, AG1
Mears, DC1
Waring, M1
Woodman, K1
Johnston, B1
Horvat, M1
Watson, J1
Koutalistras, N1
Dennis, JA1
Healy, PJ1
Reeds, PJ1
Frazer, M1
Mull, B1
Warman, AW1
Rukmini Devi, RP1
Murthy, CR1
Meyer, HP2
Legemate, DA1
van den Brom, W1
Rothuizen, J2
Schofield, JP1
Cox, TM1
Caskey, CT1
Wakamiya, M1
Sugimoto, M1
Machida, Y1
Ito, K1
Sanz, S1
Lizano, C1
Luque, J1
Pinilla, M1
Benoist, S1
Sarkis, R1
Baudrimont, M1
Delelo, R1
Robert, A1
Vaubourdolle, M1
Balladur, P1
Calmus, Y1
Capeau, J1
Nordlinger, B1
Gustin, P1
Awad, SS1
Hemmila, MR1
Soldes, OS1
Sawada, S1
Rich, PB1
Mahler, S1
Gargulinski, M1
Hirschl, RB1
Bartlett, RH1
Haigwood, JT1
Flores, RM1
Mazloumi, R1
Ngan, G1
Kelley, KM1
Ong, JP1
Torres, VE1
Cowley, BD1
Branden, MG1
Yoshida, I1
Gattone, VH1
Barr, J1
Eshel, G1
Chen-Levy, Z1
Lahat, E1
Takeyama, O1
Ikai, I1
Yagi, T1
Satoh, S1
Kanazawa, A1
Uesugi, T1
Nishitai, R1
Okabe, H1
Terajima, H1
Yamaoka, Y2
Younes, H1
Alphonse, JC1
Hadj-Abdelkader, M1
Rémésy, C1
Miyashita, T1
Fujita, Y1
Amemiya, H1
Omasa, T1
Hiramatsu, S1
Suga, K1
Matsumura, T1
Roth, VH1
Zemlyanoy, A1
Lupachyov, YU1
Tyaptin, A1
Torkounov, P1
Varlashova, M1
Novosyolova, N1
Si, J1
Zhou, W1
Joyeux, H1
Joyeux, A1
Raoux, P1
Brissac, C1
Blanc, F1
Solassol, C1
Kindt, GW1
Altenau, LL1
Wikman-Coffelt, J1
Fenner, C1
Walsh, R1
Salel, A1
Kamiyama, T1
Mason, DT1
van der Mey, T1
Blitzer, BL1
Waggoner, JG1
Gralnick, HR1
Towne, D1
Butler, J1
Weise, V1
Kopin, IJ1
Walters, I1
Teychenne, PF1
Goodman, DG1
Berk, PD1
Kamiyama, Y1
Takeda, H1
Ohshita, M1
Nambu, H1
Galmarini, D1
Tarenzi, L1
Cantaluppi, G1
Pesenti, A1
Zanandrea, G1
Girardello, D1
Doglia, M1
Fabiani, MP1
Grigolato, P1
Radice, F1
Gjedde, A1
Lockwood, A1
Duffy, TE1
Plum, F1
Tonnesen, K1
Asher, WJ1
Vogler, TC1
Bovée, KC1
Holtzapple, PG1
Hamilton, RW1
Cornelius, CE1
Himes, JA1
Gronwall, RR1
Merino, GE1
Jetzer, T1
Doizaki, WM1
Najarian, JS1
Djali, S1
Mellits, ED2
Dahn, MS1
Mitchell, RA2
Berberoglu, ED1
Lange, P1
Mukhopadhyay, A1
Sarnaik, AP1
Basile, AS1
Skolnick, P1
Uchida, M1
Yano, S1
Watanabe, K1
Filipponi, F1
Fabbri, LP1
Marsili, M1
Falcini, F1
Benassai, C1
Nucera, M1
Romagnoli, P1
DuBose, TD1
Good, DW1
Hamm, LL1
Berty, RM1
Adler, S1
Roterdamskaia, OM1
Alimov, MM1
Kasymov, AKh1
Sugimoto, T1
Woo, M1
Nishida, N1
Araki, A1
Murakami, K1
Kobayashi, Y1
Lagerstrand, L1
Hedenstierna, G1
Bartelmess, P1
Nobin, A1
Jeppsson, B1
Herlin, P1
Bugge, M1
Nath, KA1
Hostetter, MK1
Hostetter, TH1
Hart, MA1
Swisher, JA1
Caspers, ML1
Azorín, I1
Miñana, MD1
Grisolía, S1
Tateishi, K1
Kato, A1
Miura, Y1
Matsuoka, Y1
Bonato, C1
Malesci, A1
Rosati, R1
Vignati, F1
Montorsi, M1
Bersani, M1
Abbiati, R1
Salerno, F1
Fick, TE2
de Vlieger, M2
Thomas, PE1
de Haan, JG1
van Gool, J1
Van Steenbergen, TJ1
Delemarre, FG1
Namavar, F1
De Graaff, J1
Thomas, GH1
DeMuro, R1
Coyle, JT1
Reuvers, CB1
Boks, AL1
Terpstra, OT1
Jeekel, H1
ten Kate, FW1
Bruinvels, J1
Crocker, JF1
Renton, KW1
Lee, SH1
Rozee, KR1
Digout, SC1
Malatjalian, DA1
Yoder, MC1
Egler, JM1
Chatten, J1
Douglas, SD1
Polin, RA1
Drewes, LR1
Leino, RL1
Koch, MO1
McDougal, WS1
Sinniah, D1
Schwartz, PH1
Arcinue, EL1
Gushiken, T1
Yoshimura, N1
Ching, S1
Rogoff, TM1
Gabuzda, GJ1
Coppi, G1
Bonardi, G1
Lapham, LW2
Breen, KJ1
Schenker, S1
Cole, M1
Rutherford, RB1
Smith, FO1
Herz, R2
Sautter, V1
Robert, F2
Bircher, J2
Zamora, AJ1
Cavanagh, JB2
Kyu, MH2
Grange, D1
Chauvaud, S1
Thangapregassam, MJ1
Bismuth, H1
Statter, M1
Russell, A1
Abzug-Horowitz, S1
Pinson, A1
Gibson, GE1
Zimber, A1
Krook, L1
Richardson, EP1
Visek, WJ1
Ljunggren, B2
Schutz, H1
Siesjö, BK2
Ratcheson, RA1
Nichols, FA1
May, AG1
Simell, O1
Weston, MJ1
Gazzard, BG1
Buxton, BH1
Winch, J1
Machado, AL1
Flax, H1
Welbourne, TC1
Balagura-Baruch, S1
Page, CR1
Etges, FJ1
Ogle, JD1
Misra, MK1
P'eng, FK1
Sayhoun, A1
Kashii, A1
Derry, CD1
Caridis, T1
Slapak, M1
Lewis, PD1
Blakemore, WF1
Nance, FC2
Kline, DG2
Hermann, G1
Crook, JN1
Keynes, WM1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Does a Flashlight Used to Detect Pet Biological Fluids on Human Skin and Other Surfaces Increase Gas Phase Nitric Oxide Levels?[NCT04903535]100 participants (Anticipated)Interventional2021-05-10Enrolling by invitation
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity[NCT02896309]45 participants (Actual)Interventional2016-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

16 reviews available for ammonium hydroxide and Disease Models, Animal

ArticleYear
    Biomaterial investigations in dentistry, 2021, Volume: 8, Issue:1

    Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes

2021
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    Proceedings. Mathematical, physical, and engineering sciences, 2019, Volume: 475, Issue:2227

    Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, P

2019
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
The Pharmabiotic Approach to Treat Hyperammonemia.
    Nutrients, 2018, Jan-28, Volume: 10, Issue:2

    Topics: Ammonia; Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease M

2018
Comprehensive characterization of ureagenesis in the spf
    Journal of inherited metabolic disease, 2019, Volume: 42, Issue:6

    Topics: Age Factors; Aging; Ammonia; Animals; Disease Models, Animal; Humans; Hyperammonemia; Liver; Male; M

2019
Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.
    Nutrition (Burbank, Los Angeles County, Calif.), 2013, Volume: 29, Issue:10

    Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Disease Models, Animal; Glutamine; Hepatic Encephalop

2013
Nitrogen chemistry and lung physiology.
    Annual review of physiology, 2015, Volume: 77

    Topics: Amines; Ammonia; Animals; Disease Models, Animal; Humans; Lung; Lung Diseases; Nitric Oxide; Nitroge

2015
The Na-K-Cl Co-transporter in astrocyte swelling.
    Metabolic brain disease, 2010, Volume: 25, Issue:1

    Topics: Ammonia; Animals; Astrocytes; Brain; Brain Edema; Cell Size; Disease Models, Animal; Hepatic Encepha

2010
Animal models of hepatic encephalopathy and hyperammonemia.
    Advances in experimental medicine and biology, 1994, Volume: 368

    Topics: Ammonia; Animals; Disease Models, Animal; Hepatic Encephalopathy; Humans

1994
Sparse-fur (spf) mouse as a model of hyperammonemia: alterations in the neurotransmitter systems.
    Advances in experimental medicine and biology, 1997, Volume: 420

    Topics: Ammonia; Animals; Chromosome Aberrations; Chromosome Disorders; Disease Models, Animal; Gene Express

1997
Hepatic encephalopathy.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:4

    Topics: Ammonia; Animals; Disease Models, Animal; GABA-A Receptor Agonists; Hepatic Encephalopathy; Humans;

2001
Experimental liver diseases.
    Methods and achievements in experimental pathology, 1975, Volume: 7

    Topics: Alkaloids; Ammonia; Animals; Bilirubin; Budd-Chiari Syndrome; Carbon Tetrachloride Poisoning; Cattle

1975
The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
    Pharmacological reviews, 1991, Volume: 43, Issue:1

    Topics: Ammonia; Animals; Disease Models, Animal; Flumazenil; Hepatic Encephalopathy; Humans; Ligands; Neuro

1991
Ammonium transport in the kidney: new physiological concepts and their clinical implications.
    Journal of the American Society of Nephrology : JASN, 1991, Volume: 1, Issue:11

    Topics: Acidosis, Renal Tubular; Ammonia; Animals; Biological Transport, Active; Disease Models, Animal; Hum

1991
Hepatic coma: present concepts of pathogenesis and therapy.
    Progress in liver diseases, 1972, Volume: 4

    Topics: Adrenal Cortex Hormones; Amino Acids; Ammonia; Animals; Anti-Bacterial Agents; Biogenic Amines; Brai

1972

Trials

4 trials available for ammonium hydroxide and Disease Models, Animal

ArticleYear
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
An engineered
    Science translational medicine, 2019, 01-16, Volume: 11, Issue:475

    Topics: Ammonia; Animals; Arginine; Biosynthetic Pathways; Disease Models, Animal; Escherichia coli; Feces;

2019
Ammonia impairs neutrophil phagocytic function in liver disease.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Amino Acids; Ammonia; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Double-Blind

2008

Other Studies

263 other studies available for ammonium hydroxide and Disease Models, Animal

ArticleYear
Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model.
    Journal of inherited metabolic disease, 2022, Volume: 45, Issue:3

    Topics: Ammonia; Animals; Disease Models, Animal; Glutaminase; Glutamine; Humans; Hyperammonemia; Liver; Mic

2022
Sex is associated with differences in oxidative stress and susceptibility to severe hepatic encephalopathy in bile-duct ligated rats.
    Journal of neurochemistry, 2022, Volume: 162, Issue:4

    Topics: Allopurinol; Ammonia; Animals; Bile; Disease Models, Animal; Female; Hepatic Encephalopathy; Hyperam

2022
O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis.
    Nature communications, 2022, 09-05, Volume: 13, Issue:1

    Topics: Acetylglucosamine; Ammonia; Animals; Biocatalysis; Carbamoyl-Phosphate Synthase (Ammonia); Disease M

2022
Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.
    Journal of inherited metabolic disease, 2023, Volume: 46, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Amino Acid Transport Systems, Neutral; Ammonia; Animals; Disea

2023
A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.
    Scientific reports, 2022, 10-20, Volume: 12, Issue:1

    Topics: Ammonia; Animals; Bile Acids and Salts; Bile Ducts; Brain; Choline; Disease Models, Animal; Glutamin

2022
Establishment of acute liver failure model in Tibetan miniature pig and verified by dual plasma molecular adsorption system.
    The International journal of artificial organs, 2023, Volume: 46, Issue:3

    Topics: Adsorption; Ammonia; Animals; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Liv

2023
Poly(ornithine)-based self-assembling drug for recovery of hyperammonemia and damage in acute liver injury.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 09-28, Volume: 310

    Topics: Acetaminophen; Ammonia; Animals; Cattle; Cell Survival; Chemical and Drug Induced Liver Injury; Chon

2019
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 10-15, Volume: 116, Issue:42

    Topics: Ammonia; Animals; Arginase; Arginine; Codon; Disease Models, Animal; Glutamine; Hyperammonemia; Hype

2019
BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
    Journal of ethnopharmacology, 2020, Mar-01, Volume: 249

    Topics: Ammonia; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Hepatic Encephalopathy; Inflamma

2020
High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.
    Pharmacology, biochemistry, and behavior, 2020, Volume: 192

    Topics: Ammonia; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Glutamic

2020
Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2020, 07-08, Volume: 28, Issue:7

    Topics: Ammonia; Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency

2020
An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure.
    Nature biomedical engineering, 2020, Volume: 4, Issue:9

    Topics: Administration, Oral; Alginates; Ammonia; Animals; Bacteria; Capsules; Creatinine; Disease Models, A

2020
Yan-Hou-Qing formula attenuates ammonia-induced acute pharyngitis in rats via inhibition of NF-κB and COX-2.
    BMC complementary medicine and therapies, 2020, Sep-14, Volume: 20, Issue:1

    Topics: Ammonia; Animals; China; Cyclooxygenase 2; Disease Models, Animal; Drugs, Chinese Herbal; Female; Mo

2020
Effects of resveratrol on alterations in cerebrum energy metabolism caused by metabolites accumulated in type I citrullinemia in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:5

    Topics: Ammonia; Animals; Cerebellum; Cerebral Cortex; Citrulline; Citrullinemia; Disease Models, Animal; Do

2021
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
    Journal of inherited metabolic disease, 2021, Volume: 44, Issue:3

    Topics: Ammonia; Animals; Child, Preschool; Disease Models, Animal; Female; Gene Expression Regulation; Hepa

2021
Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammonia.
    Journal of neurochemistry, 2021, Volume: 157, Issue:3

    Topics: Ammonia; Animals; Antigens, Nuclear; Anxiety; Apoptosis; Behavior, Animal; Bile Ducts; Caspase 3; Ce

2021
Potassium deficiency decreases the capacity for urea synthesis and markedly increases ammonia in rats.
    American journal of physiology. Gastrointestinal and liver physiology, 2021, 04-01, Volume: 320, Issue:4

    Topics: Ammonia; Animals; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Hyperammo

2021
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2021, 05-05, Volume: 29, Issue:5

    Topics: Adult; Aged; Ammonia; Animals; Cells, Cultured; Child; Disease Models, Animal; Female; Gene Editing;

2021
Sirtuin-3 activation by honokiol restores mitochondrial dysfunction in the hippocampus of the hepatic encephalopathy rat model of ammonia neurotoxicity.
    Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:5

    Topics: Ammonia; Animals; Disease Models, Animal; Hepatic Encephalopathy; Hippocampus; Male; Mitochondria; N

2021
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target.
    mBio, 2021, 04-20, Volume: 12, Issue:2

    Topics: Ammonia; Animals; Bacterial Proteins; Caenorhabditis elegans; Cell Line; Disease Models, Animal; Dro

2021
Oral administration of trace element magnesium significantly improving the cognition and locomotion in hepatic encephalopathy rats.
    Scientific reports, 2017, 05-12, Volume: 7, Issue:1

    Topics: Administration, Oral; Ammonia; Animals; Brain; Cognition; Dietary Supplements; Disease Models, Anima

2017
Ameliorative effects of rutin on hepatic encephalopathy-induced by thioacetamide or gamma irradiation.
    Journal of photochemistry and photobiology. B, Biology, 2017, Volume: 172

    Topics: Acetylcholinesterase; Administration, Oral; Alanine Transaminase; Ammonia; Animals; Aspartate Aminot

2017
Hyperammonemia compromises glutamate metabolism and reduces BDNF in the rat hippocampus.
    Neurotoxicology, 2017, Volume: 62

    Topics: Ammonia; Animals; Animals, Newborn; Astrocytes; Brain-Derived Neurotrophic Factor; Cells, Cultured;

2017
Artificial liver support in pigs with acetaminophen-induced acute liver failure.
    World journal of gastroenterology, 2017, May-14, Volume: 23, Issue:18

    Topics: Acetaminophen; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Cell Nucleus; Creatinine; D

2017
Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats.
    Metabolic brain disease, 2017, Volume: 32, Issue:6

    Topics: Ammonia; Animals; Aquaporin 4; Aspartate Aminotransferases; Behavior, Animal; Bilirubin; Creatinine;

2017
Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2017, Sep-21, Volume: 50, Issue:11

    Topics: Alanine Transaminase; Ammonia; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Bip

2017
Polysaccharides from Citrus grandis L. Osbeck suppress inflammation and relieve chronic pharyngitis.
    Microbial pathogenesis, 2017, Volume: 113

    Topics: Ammonia; Animals; Citrus; Cytokines; Disease Models, Animal; HEK293 Cells; Humans; I-kappa B Kinase;

2017
Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure.
    World journal of gastroenterology, 2017, Nov-14, Volume: 23, Issue:42

    Topics: Ammonia; Animals; Disease Models, Animal; Galactosamine; Intracranial Pressure; Liver Failure, Acute

2017
Antitussive and expectorant activities of licorice and its major compounds.
    Bioorganic & medicinal chemistry, 2018, 01-01, Volume: 26, Issue:1

    Topics: Administration, Oral; Ammonia; Animals; Antitussive Agents; Cough; Disease Models, Animal; Dose-Resp

2018
Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis.
    Medical hypotheses, 2018, Volume: 113

    Topics: Ammonia; Animals; Biopsy; Disease Models, Animal; Disease Progression; Fibrosis; Hepatic Stellate Ce

2018
Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria.
    Journal of neuroinflammation, 2018, Jun-04, Volume: 15, Issue:1

    Topics: Ammonia; Animals; Antibodies; Anticoagulants; Blood Vessels; Cytokines; Disease Models, Animal; Fibr

2018
Ammonia role in glial dysfunction in methylmalonic acidemia.
    Toxicology letters, 2018, Oct-01, Volume: 295

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Ammonium Chloride; Animals; Behavior, Animal; Brain;

2018
Effect of tumor necrosis factor-α on the expression of the ammonia transporter Rhcg in the brain in mice with acute liver failure.
    Journal of neuroinflammation, 2018, Aug-22, Volume: 15, Issue:1

    Topics: Ammonia; Analysis of Variance; Animals; Brain; Cation Transport Proteins; Disease Models, Animal; Do

2018
Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure.
    EBioMedicine, 2018, Volume: 37

    Topics: Ammonia; Animals; Bile Acids and Salts; Cell Line; Disease Models, Animal; End Stage Liver Disease;

2018
Aloin Inhibits Müller Cells Swelling in a Rat Model of Thioacetamide-Induced Hepatic Retinopathy.
    Molecules (Basel, Switzerland), 2018, Oct-29, Volume: 23, Issue:11

    Topics: Ammonia; Animals; Aquaporin 4; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Emodi

2018
Progressive resistance training prevents loss of muscle mass and strength in bile duct-ligated rats.
    Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:4

    Topics: Ammonia; Animals; Bile Ducts; Body Composition; Disease Models, Animal; Hepatic Encephalopathy; Hype

2019
Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
    Journal of inherited metabolic disease, 2019, Volume: 42, Issue:6

    Topics: Ammonia; Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency

2019
Taurine transporter (TauT) deficiency impairs ammonia detoxification in mouse liver.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 03-26, Volume: 116, Issue:13

    Topics: Ammonia; Animals; Deficiency Diseases; Disease Models, Animal; GABA Plasma Membrane Transport Protei

2019
Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.
    Scientific reports, 2019, 03-12, Volume: 9, Issue:1

    Topics: Amino Acids; Ammonia; Ammonium Chloride; Animals; Aspartic Acid; Citrulline; Citrullinemia; Disease

2019
In-solution behavior and protective potential of asparagine synthetase A from Trypanosoma cruzi.
    Molecular and biochemical parasitology, 2019, Volume: 230

    Topics: Ammonia; Animals; Asparagine; Aspartate-Ammonia Ligase; Chagas Disease; Chromatography, Liquid; Circ

2019
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease.
    Hepatology (Baltimore, Md.), 2020, Volume: 71, Issue:3

    Topics: Ammonia; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Female; Humans; Live

2020
Evaluation of the Hepa Wash® treatment in pigs with acute liver failure.
    BMC gastroenterology, 2013, May-13, Volume: 13

    Topics: Ammonia; Animals; Blood Pressure; Cardiac Output; Creatinine; Dialysis; Disease Models, Animal; Fema

2013
Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:3

    Topics: Ammonia; Animals; Azoxymethane; Blood-Brain Barrier; Cytokines; Disease Models, Animal; Hepatic Ence

2014
Liver-directed adeno-associated virus serotype 8 gene transfer rescues a lethal murine model of citrullinemia type 1.
    Gene therapy, 2013, Volume: 20, Issue:12

    Topics: Ammonia; Animals; Argininosuccinate Synthase; Citrulline; Citrullinemia; Dependovirus; Disease Model

2013
Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy.
    Journal of neurochemistry, 2014, Volume: 128, Issue:6

    Topics: Acute Disease; Ammonia; Animals; Astrocytes; Brain Edema; Cell Communication; Cells, Cultured; Cereb

2014
Knockdown of asparagine synthetase A renders Trypanosoma brucei auxotrophic to asparagine.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:12

    Topics: Adenosine Triphosphate; Ammonia; Animals; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Aspart

2013
Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
    Journal of hepatology, 2014, Volume: 60, Issue:3

    Topics: Ammonia; Animals; Bile Ducts; Disease Models, Animal; End Stage Liver Disease; Glutamate-Ammonia Lig

2014
Differential up-regulation of ammonia detoxifying enzymes in cerebral cortex, cerebellum, hippocampus, striatum and liver in hyperammonemia.
    CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:6

    Topics: Alanine Transaminase; Ammonia; AMP Deaminase; Animals; Aspartate Aminotransferases; Brain; Disease M

2014
Imaging of cardiac and renal perfusion in a rat model with 13N-NH 3 micro-PET.
    The international journal of cardiovascular imaging, 2015, Volume: 31, Issue:1

    Topics: Ammonia; Animals; Coronary Circulation; Disease Models, Animal; Male; Myocardial Infarction; Myocard

2015
L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.
    American journal of physiology. Gastrointestinal and liver physiology, 2014, Nov-15, Volume: 307, Issue:10

    Topics: Ammonia; Animals; Biomarkers; Brain; Disease Models, Animal; Female; Glycine; Hyperammonemia; Kidney

2014
Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.
    Gene therapy, 2015, Volume: 22, Issue:2

    Topics: Ammonia; Animals; Arginase; Dependovirus; Disease Models, Animal; Genetic Therapy; Hyperammonemia; H

2015
Impaired expression of key molecules of ammoniagenesis underlies renal acidosis in a rat model of chronic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015, Volume: 30, Issue:5

    Topics: Acidosis; Amino Acid Transport Systems, Neutral; Ammonia; Animals; Bicarbonates; Creatinine; Disease

2015
pH-sensitive microemulsion-based gels for removal of colonic ammonia: a novel preventative oral preparation for hepatic encephalopathy in rats.
    Molecular medicine reports, 2015, Volume: 11, Issue:5

    Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Body Weight; Disease Models, Animal; Electroencep

2015
Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3

    Topics: Ammonia; Animals; Arrhythmias, Cardiac; Carbon Radioisotopes; Catecholamines; Disease Models, Animal

2015
Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection.
    Transplantation, 2015, Volume: 99, Issue:9

    Topics: Allografts; Ammonia; Animals; Diet, Carbohydrate-Restricted; Disease Models, Animal; Fluorodeoxygluc

2015
Behavioral alterations and Fos protein immunoreactivity in brain regions of bile duct-ligated cirrhotic rats.
    Anais da Academia Brasileira de Ciencias, 2015, Volume: 87, Issue:1

    Topics: Ammonia; Animals; Anxiety; Behavior, Animal; Bile Ducts; Brain Chemistry; Disease Models, Animal; Im

2015
Integrated compensatory network is activated in the absence of NCC phosphorylation.
    The Journal of clinical investigation, 2015, Volume: 125, Issue:5

    Topics: Amiloride; Ammonia; Animals; Biological Transport; Blood Pressure; Carbonic Anhydrases; Chlorides; D

2015
D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?
    Medical science monitor : international medical journal of experimental and clinical research, 2015, May-22, Volume: 21

    Topics: Acute Kidney Injury; Alanine Transaminase; Albumins; Ammonia; Animals; Aspartate Aminotransferases;

2015
Engineering the gut microbiota to treat hyperammonemia.
    The Journal of clinical investigation, 2015, Jul-01, Volume: 125, Issue:7

    Topics: Ammonia; Animals; Bacteria; Bacterial Proteins; Bioengineering; Biological Therapy; Chemical and Dru

2015
Antitussive, expectorant, and anti-inflammatory activities of four caffeoylquinic acids isolated from Tussilago farfara.
    Pharmaceutical biology, 2016, Volume: 54, Issue:7

    Topics: Acetates; Ammonia; Animals; Anti-Inflammatory Agents; Antitussive Agents; Cough; Disease Models, Ani

2016
The Influence of Finasteride on Mean and Relative Spectral Density of EEG Bands in Rat Model of Thioacetamide-Induced Hepatic Encephalopathy.
    Neurotoxicity research, 2016, Volume: 30, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Ammonia; Animals; Brain; Brain Waves; Central Nervous System Agents; D

2016
Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
    Neuropharmacology, 2016, Volume: 107

    Topics: Ammonia; Animals; Blood-Brain Barrier; Capillaries; Capillary Permeability; Central Nervous System S

2016
Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin.
    European journal of pharmacology, 2016, May-15, Volume: 779

    Topics: Ammonia; Animals; Behavior, Animal; Brain; Coma; Disease Models, Animal; Hepatic Encephalopathy; Hyp

2016
Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.
    Molecular neurobiology, 2017, Volume: 54, Issue:5

    Topics: Ammonia; Animals; Biomarkers; Brain; Coma; Disease Models, Animal; Electroencephalography; Guanosine

2017
Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 06-22, Volume: 36, Issue:25

    Topics: Action Potentials; Ammonia; Animals; Animals, Newborn; Arginase; Disease Models, Animal; Genetic The

2016
Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Journal of digestive diseases, 2016, Volume: 17, Issue:7

    Topics: Ammonia; Animals; Colon; Dilatation; Disease Models, Animal; Feces; Glutamic Acid; Intestinal Mucosa

2016
Novel Combination of Prebiotics Galacto-Oligosaccharides and Inulin-Inhibited Aberrant Crypt Foci Formation and Biomarkers of Colon Cancer in Wistar Rats.
    Nutrients, 2016, Aug-01, Volume: 8, Issue:8

    Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; Ammonia; Animals; Anticarcinogenic Agents; Bacterial Pro

2016
Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect.
    The Journal of biological chemistry, 2016, 09-23, Volume: 291, Issue:39

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Biomarkers; Brain; Carnitine; Dietary Protei

2016
Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Ammonia; Animals; Disease Models, Animal; Hyperammonemia; Immunocompromised Host; Immunosuppressive

2016
NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility.
    Brain structure & function, 2017, Volume: 222, Issue:3

    Topics: Ammonia; Animals; Animals, Newborn; Bumetanide; Cell Count; Cerebral Cortex; Disease Models, Animal;

2017
The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis.
    Metabolic brain disease, 2017, Volume: 32, Issue:2

    Topics: Ammonia; Animals; Base Composition; Bile Ducts; Disease Models, Animal; Eating; Hepatic Encephalopat

2017
Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:4

    Topics: Ammonia; Analysis of Variance; Animals; Bile Ducts; Biomarkers; Blotting, Western; Cerebral Cortex;

2017
Cortical Synaptic Transmission and Plasticity in Acute Liver Failure Are Decreased by Presynaptic Events.
    Molecular neurobiology, 2018, Volume: 55, Issue:2

    Topics: Ammonia; Animals; Cerebral Cortex; Cytokines; Disease Models, Animal; Liver Failure, Acute; Male; Mi

2018
Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:6

    Topics: Ammonia; Analysis of Variance; Animals; Autophagy; Disease Models, Animal; Homeostasis; Hyperammonem

2017
Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction.
    Journal of the American College of Cardiology, 2008, Jun-10, Volume: 51, Issue:23

    Topics: Ammonia; Animals; Catecholamines; Disease Models, Animal; Epinephrine; Heart; Magnetic Resonance Ima

2008
Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
    American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 295, Issue:3

    Topics: Ammonia; Animals; Brain; Disease Models, Animal; Disease Progression; Dizocilpine Maleate; Excitator

2008
Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:1

    Topics: Adult; Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetra

2009
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2008, Volume: 24, Issue:142

    Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocyte

2008
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Acute Disease; Alanine; Ammonia; Animals; Carbon Tetrachloride; Chronic Disease; Disease Models, Ani

2008
Plasma exchange-based plasma recycling dialysis system as an artificial liver support.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12, Issue:4

    Topics: Ammonia; Animals; Anion Exchange Resins; Bile Acids and Salts; Bilirubin; Charcoal; Dialysis; Diseas

2008
Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia.
    Metabolic brain disease, 2009, Volume: 24, Issue:1

    Topics: Ammonia; Animals; Astrocytes; Brain; Carbon Radioisotopes; Cells, Cultured; Cholestasis; Citric Acid

2009
Expanding the versatility of cardiac PET/CT: feasibility of delayed contrast enhancement CT for infarct detection in a porcine model.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:2

    Topics: Ammonia; Animals; Contrast Media; Disease Models, Animal; Myocardial Infarction; Myocardial Perfusio

2009
Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:5

    Topics: Ammonia; Animals; Brain Edema; CD11b Antigen; Cytokines; Disease Models, Animal; Gene Expression; He

2009
Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.
    Gastroenterology, 2009, Volume: 137, Issue:1

    Topics: Age Factors; Ammonia; Animals; Animals, Newborn; Base Sequence; Carbamoyl-Phosphate Synthase (Ammoni

2009
Technical breakthroughs in the wearable artificial kidney (WAK).
    Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:9

    Topics: Ammonia; Animals; beta 2-Microglobulin; Biomarkers; Charcoal; Creatinine; Dialysis Solutions; Diseas

2009
AMP deaminase and adenosine deaminase activities in liver and brain regions in acute ammonia intoxication and subacute toxic hepatitis.
    Brain research, 2010, Jan-22, Volume: 1311

    Topics: Acute Disease; Adenine Nucleotides; Adenosine Deaminase; Ammonia; AMP Deaminase; Animals; Brain; Car

2010
Glutamine synthetase deficiency in murine astrocytes results in neonatal death.
    Glia, 2010, Apr-15, Volume: 58, Issue:6

    Topics: Adenylate Kinase; Amino Acids; Ammonia; Analysis of Variance; Animals; Animals, Newborn; Astrocytes;

2010
Portacaval anastomosis-induced hyperammonemia does not lead to oxidative stress.
    Metabolic brain disease, 2010, Volume: 25, Issue:1

    Topics: Aldehydes; Ammonia; Animals; Biomarkers; Blotting, Western; Brain; Disease Models, Animal; Frontal L

2010
Effect of intercalated cell-specific Rh C glycoprotein deletion on basal and metabolic acidosis-stimulated renal ammonia excretion.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:2

    Topics: Acidosis; Adaptation, Physiological; Ammonia; Animals; Bicarbonates; Cation Transport Proteins; Dise

2010
A new experimental model for acute hepatic failure in rats.
    Acta cirurgica brasileira, 2010, Volume: 25, Issue:3

    Topics: Ammonia; Animals; Bilirubin; Creatine; Disease Models, Animal; Hepatectomy; Hepatic Encephalopathy;

2010
Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle.
    Amino acids, 2011, Volume: 40, Issue:2

    Topics: Acute Disease; Amino Acids, Branched-Chain; Ammonia; Animals; Disease Models, Animal; Extracellular

2011
New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.
    Journal of hepatology, 2011, Volume: 55, Issue:2

    Topics: Acyl Coenzyme A; Amino-Acid N-Acetyltransferase; Ammonia; Animals; Anticonvulsants; Citrulline; Dise

2011
Influence of rutin on biochemical alterations in hyperammonemia in rats.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2012, Volume: 64, Issue:7-8

    Topics: Administration, Oral; Ammonia; Animals; Antioxidants; Body Weight; Brain; Disease Models, Animal; Hy

2012
Microglia activation in hepatic encephalopathy in rats and humans.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1

    Topics: Ammonia; Animals; Astrocytes; Autopsy; Calcium-Binding Proteins; Cell Movement; Cells, Cultured; Cer

2011
Neuromonitoring in a porcine model of acute hepatic failure.
    Laboratory animals, 2011, Volume: 45, Issue:3

    Topics: Ammonia; Animals; Brain Edema; Cerebral Cortex; Disease Models, Animal; Electroencephalography; Evok

2011
p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.
    Gut, 2011, Volume: 60, Issue:11

    Topics: Ammonia; Animals; Blotting, Western; Cerebellum; Cerebral Cortex; Cognition; Disease Models, Animal;

2011
Development of a porcine model of post-hepatectomy liver failure.
    The Journal of surgical research, 2011, Volume: 170, Issue:2

    Topics: Ammonia; Animals; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Female; Hepatecto

2011
Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
    Journal of hepatology, 2012, Volume: 56, Issue:1

    Topics: Amino Acids; Ammonia; Animals; Brain; Disease Models, Animal; Evoked Potentials, Motor; Glutamine; H

2012
Metabolomic analysis reveals hepatic metabolite perturbations in citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mice, a model of human citrin deficiency.
    Molecular genetics and metabolism, 2011, Volume: 104, Issue:4

    Topics: Ammonia; Animals; Calcium-Binding Proteins; Citric Acid Cycle; Disease Models, Animal; Electrophores

2011
β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice.
    Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:3

    Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; beta Catenin; Disease Models, A

2012
Exploratory investigation on nitro- and phospho-proteome cerebellum changes in hyperammonemia and hepatic encephalopathy rat models.
    Metabolic brain disease, 2012, Volume: 27, Issue:1

    Topics: Ammonia; Animals; Cerebellum; Cognition; Disease Models, Animal; Hepatic Encephalopathy; Humans; Hyp

2012
Ammonia-induced brain swelling and neurotoxicity in an organotypic slice model.
    Neurological research, 2011, Volume: 33, Issue:10

    Topics: Ammonia; Animals; Animals, Newborn; Brain; Brain Edema; Disease Models, Animal; Hepatic Encephalopat

2011
Metabolomic profiling of the flower bud and rachis of Tussilago farfara with antitussive and expectorant effects on mice.
    Journal of ethnopharmacology, 2012, Mar-06, Volume: 140, Issue:1

    Topics: Ammonia; Animals; Antitussive Agents; Chlorogenic Acid; Cough; Disease Models, Animal; Drug Contamin

2012
Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure.
    Free radical biology & medicine, 2012, Apr-01, Volume: 52, Issue:7

    Topics: Ammonia; Animals; Blood-Brain Barrier; Brain Edema; Disease Models, Animal; End Stage Liver Disease;

2012
Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study.
    The International journal of artificial organs, 2012, Volume: 35, Issue:7

    Topics: Ammonia; Animals; Bilirubin; Biomarkers; Cerebrovascular Circulation; Disease Models, Animal; Equipm

2012
Long-term activation of semicarbazide-sensitive amine oxidase lowers circulating levels of uric acid in diabetic conditions.
    Physiological research, 2012, Volume: 61, Issue:3

    Topics: Amine Oxidase (Copper-Containing); Ammonia; Animals; Benzylamines; Blood Glucose; Cell Adhesion Mole

2012
Chronic postnatal ornithine administration to rats provokes learning deficit in the open field task.
    Metabolic brain disease, 2012, Volume: 27, Issue:4

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Animals, Newborn; Avoidance Learning; Behavi

2012
Peripheral ammonia as a mediator of methamphetamine neurotoxicity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Sep-19, Volume: 32, Issue:38

    Topics: Alanine Transaminase; Ammonia; Analysis of Variance; Animals; Aspartate Aminotransferases; Benzodiaz

2012
Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:4

    Topics: Amino Acids; Ammonia; Animals; Apolipoprotein A-I; Cell Line, Tumor; Cytochrome P-450 CYP3A; Disease

2013
Ammonia aggravates stress-induced gastric mucosal oxidative injury through the cancellation of cytoprotective heat shock protein 70.
    Free radical biology & medicine, 2002, Oct-15, Volume: 33, Issue:8

    Topics: Ammonia; Animals; Disease Models, Animal; Electroshock; Emotions; Free Radicals; Gastric Mucosa; Gen

2002
The development of a new bioartificial liver and its application in 12 acute liver failure patients.
    World journal of gastroenterology, 2003, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Ammonia; Animals; Bilirubin; Disease Models, Animal; Equipment Design; Female; He

2003
The relationship between the level of thirteen different substances and enzymes in blood and peritoneal fluid and the duration of mechanical intestinal obstruction: an experimental study on rats.
    Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2003, Volume: 9, Issue:3

    Topics: Ammonia; Animals; Ascitic Fluid; Blood Chemical Analysis; Disease Models, Animal; Fructose-Bisphosph

2003
Tochu (Eucommia ulmoides) leaf extract prevents ammonia and vitamin C deficiency induced gastric mucosal injury.
    Life sciences, 2003, Nov-07, Volume: 73, Issue:25

    Topics: Ammonia; Animals; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; Ascorbic Acid Deficiency; Cell Div

2003
Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia.
    Molecular and cellular biology, 2004, Volume: 24, Issue:2

    Topics: Amino Acids; Ammonia; Animals; Argininosuccinate Synthase; Aspartic Acid; Base Sequence; Citrullinem

2004
Rabbit retinal organ culture as an in-vitro model of hepatic retinopathy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:6

    Topics: Ammonia; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glial Fibrillary A

2004
Efficacy of immunoadsorbent devices for maintaining hepatic function in ex vivo direct xenogenic hemoperfusion.
    The International journal of artificial organs, 2004, Volume: 27, Issue:4

    Topics: Alanine Transaminase; Ammonia; Animals; Bioreactors; Disease Models, Animal; Dogs; Graft Rejection;

2004
Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori.
    Molecular microbiology, 2004, Volume: 53, Issue:2

    Topics: Acids; Adaptation, Physiological; Amidohydrolases; Ammonia; Animals; Bacterial Proteins; Buffers; Di

2004
Chronic gastritis rat model and role of inducing factors.
    World journal of gastroenterology, 2004, Nov-01, Volume: 10, Issue:21

    Topics: Alcohols; Ammonia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrophy; Chronic Disease; Deoxy

2004
[Description of an experimental model of hepatorenal syndrome in Wistar rats].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:98

    Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Anim

2004
Hyperammonaemia reduces intracellular 22Na (sodium) ion and extracellular 86Rb ion concentrations in the blood-brain barrier of the rat.
    Metabolic brain disease, 2005, Volume: 20, Issue:1

    Topics: Ammonia; Animals; Blood-Brain Barrier; Carbon Radioisotopes; Choroid Plexus; Diffusion; Disease Mode

2005
An experimental animal model of fulminant hepatic failure in pigs.
    Journal of Korean medical science, 2005, Volume: 20, Issue:3

    Topics: Acidosis; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Urea Nitrog

2005
Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study.
    Critical care medicine, 2006, Volume: 34, Issue:1

    Topics: Albumins; Ammonia; Animals; Brain Edema; Cerebrovascular Circulation; Disease Models, Animal; Female

2006
Functional evaluation of a new bioartificial liver system in vitro and in vitro.
    World journal of gastroenterology, 2006, Feb-28, Volume: 12, Issue:8

    Topics: Alanine Transaminase; Albumins; Ammonia; Animals; Bilirubin; Bioreactors; Cell Survival; Cells, Cult

2006
Citrate therapy in Dent's disease.
    Kidney international, 2006, Volume: 69, Issue:10

    Topics: Acidosis; Ammonia; Animals; Chronic Disease; Citrates; Disease Models, Animal; Humans; Hydrogen-Ion

2006
Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.
    World journal of gastroenterology, 2006, Apr-21, Volume: 12, Issue:15

    Topics: Ammonia; Animals; Basal Ganglia; Cerebral Cortex; Disease Models, Animal; Duodenum; Glutaminase; Hep

2006
A latex-induced allergic airway inflammation model in mice.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 99, Issue:6

    Topics: Allergens; Ammonia; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Immu

2006
Protective effects of Gingko biloba on thioacetamide-induced fulminant hepatic failure in rats.
    Human & experimental toxicology, 2006, Volume: 25, Issue:12

    Topics: Acetylcysteine; Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Chem

2006
Endotoxemia produces coma and brain swelling in bile duct ligated rats.
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:6

    Topics: Ammonia; Animals; Brain; Brain Edema; Capillaries; Cholestasis, Extrahepatic; Coma; Consciousness; C

2007
Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:7 Pt 2

    Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Anim

2008
Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:6

    Topics: Ammonia; Animals; Brain Chemistry; Disease Models, Animal; Extracellular Space; Female; Glutamic Aci

2007
Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:6

    Topics: Alanine; Ammonia; Animals; Arginine; Citrulline; Disease Models, Animal; Female; Glycine; Injections

2007
Cerebral blood flow autoregulation in experimental liver failure.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2008, Volume: 28, Issue:5

    Topics: Ammonia; Animals; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Anim

2008
Gene expression profiling of astrocytes from hyperammonemic mice reveals altered pathways for water and potassium homeostasis in vivo.
    Glia, 2008, Volume: 56, Issue:4

    Topics: Amino Acids; Ammonia; Animals; Aquaporin 4; Astrocytes; Connexin 43; Diet, Reducing; Disease Models,

2008
Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis.
    American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:4

    Topics: Acidosis; Ammonia; Ammonium Chloride; Angiotensin II; Animals; Disease Models, Animal; Kidney Cortex

2008
[Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure].
    Leber, Magen, Darm, 1984, Volume: 14, Issue:6

    Topics: Ammonia; Animals; Arousal; Brain; Disease Models, Animal; Electroencephalography; Evoked Potentials,

1984
Altered auditory brainstem evoked responses in the ferret model for Reye's syndrome.
    International journal of pediatric otorhinolaryngology, 1984, Volume: 7, Issue:3

    Topics: Ammonia; Animals; Aspirin; Audiometry; Audiometry, Evoked Response; Brain Stem; Disease Models, Anim

1984
Large-pore hemodialytic procedures in pigs with ischemic hepatic necrosis; a randomized study.
    Hepato-gastroenterology, 1984, Volume: 31, Issue:6

    Topics: Ammonia; Animals; Blood; Disease Models, Animal; Electroencephalography; Hepatic Encephalopathy; Isc

1984
Free fatty acids in an animal model of Reye's syndrome.
    Biochimica et biophysica acta, 1983, Sep-20, Volume: 753, Issue:2

    Topics: Ammonia; Animals; Aspirin; Carnivora; Diet; Disease Models, Animal; Fatty Acids, Nonesterified; Ferr

1983
Fatty liver and kidney syndrome in chickens as an animal model for Reye's syndrome.
    Journal of pediatric gastroenterology and nutrition, 1983, Volume: 2, Issue:4

    Topics: Ammonia; Animals; Blood Glucose; Carbon-Carbon Ligases; Carboxy-Lyases; Chickens; Disease Models, An

1983
Increased tryptophan uptake into the brain in hyperammonemia.
    Life sciences, 1983, Dec-12, Volume: 33, Issue:24

    Topics: Amino Acids; Ammonia; Animals; Brain; Brain Stem; Disease Models, Animal; Indoles; Male; Probenecid;

1983
Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
    Gastroenterology, 1984, Volume: 86, Issue:3

    Topics: Ammonia; Animals; Caprylates; Disease Models, Animal; Disulfides; Evoked Potentials, Visual; Galacto

1984
Hepatocyte heterogeneity in ammonia metabolism: impairment of glutamine synthesis in CCl4 induced liver cell necrosis with no effect on urea synthesis.
    Chemico-biological interactions, 1984, Volume: 48, Issue:2

    Topics: Ammonia; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Disease Mo

1984
[Hyperammonemia and decrease of growth and nocturnal locomotion in rats with portal stricture and uremia].
    Pathologie-biologie, 1984, Volume: 32, Issue:4

    Topics: Ammonia; Animals; Constriction, Pathologic; Disease Models, Animal; Growth Disorders; Male; Motor Ac

1984
Hypoglycin toxicity: studies of ammonia metabolism.
    Biochemical pharmacology, 1983, Feb-15, Volume: 32, Issue:4

    Topics: Ammonia; Animals; Citrulline; Cyclopropanes; Disease Models, Animal; Humans; Hypoglycins; Liver; Nit

1983
The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models.
    The Journal of pathology, 1983, Volume: 140, Issue:4

    Topics: Ammonia; Animals; Astrocytes; Brain; Carbon Tetrachloride Poisoning; Cation Exchange Resins; Cerebel

1983
The brain in experimental portal-systemic encephalopathy. II. Water and electrolyte changes.
    The Journal of pathology, 1983, Volume: 140, Issue:4

    Topics: Ammonia; Animals; Blood Proteins; Body Water; Brain; Cation Exchange Resins; Chlorides; Disease Mode

1983
The sparse fur mouse: an animal model for a human inborn error of metabolism of the urea cycle.
    Progress in clinical and biological research, 1983, Volume: 127

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Carbamyl Phosphate; Disease Models, Animal;

1983
Interactions of aspirin and other potential etiologic factors in an animal model of Reye syndrome.
    Proceedings of the National Academy of Sciences of the United States of America, 1982, Volume: 79, Issue:23

    Topics: Ammonia; Animals; Arginine; Aspartate Aminotransferases; Aspirin; Diet; Disease Models, Animal; Ferr

1982
Serum enzyme alterations in arginine-deficient, influenza-infected ferrets: a potential animal model of Reye's syndrome.
    Enzyme, 1982, Volume: 27, Issue:1

    Topics: Ammonia; Animals; Arginine; Aspartate Aminotransferases; Disease Models, Animal; Ferrets; Humans; In

1982
Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.
    Gastroenterologia Japonica, 1982, Volume: 17, Issue:2

    Topics: Ammonia; Animals; Brain; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepatic Enc

1982
[Hepatic coma - experimental study with swine (part 1)].
    Zeitschrift fur experimentelle Chirurgie, 1981, Volume: 14, Issue:1

    Topics: Acetamides; Ammonia; Animals; Creatinine; Disease Models, Animal; Electrolytes; Enzymes; Female; Hep

1981
Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
    Journal of neurochemistry, 1995, Volume: 64, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Amino Acids; Ammonia; Animals; Biogenic Monoamines; B

1995
[The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1995, Volume: 105, Issue:5

    Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Dogs; Hepatic Encephalopathy; Lactulose; Male

1995
Mechanism for lowering blood ammonia levels by lactitol.
    Japanese journal of pharmacology, 1995, Volume: 67, Issue:4

    Topics: Acetates; Administration, Oral; Ammonia; Animals; Cecum; Charcoal; Colon; Disease Models, Animal; Ga

1995
[Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1995, Volume: 105, Issue:2

    Topics: Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Lactulose; Male; Rats; Rats

1995
Oceanography and environmental sciences at Miami.
    Environmental health perspectives, 1995, Volume: 103, Issue:3

    Topics: Ammonia; Animals; Carcinogenicity Tests; Disease Models, Animal; Fishes; Marine Toxins; Neurofibroma

1995
Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1994, Volume: 93, Issue:6

    Topics: Amino Acids, Essential; Ammonia; Animals; Brain Diseases; Disease Models, Animal; Humans; Male; Pare

1994
[Preventive effects of troxipide on a newly developed model of acute gastric mucosal lesion (AGML) induced by ischemia/reperfusion plus ammonia in the rat].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1994, Volume: 104, Issue:4

    Topics: Acute Disease; Ammonia; Animals; Disease Models, Animal; Gastric Mucosa; Male; Piperidines; Rats; Ra

1994
Effects of zinc on hepatic ornithine transcarbamylase (OTC) activity.
    Journal of trace elements and electrolytes in health and disease, 1993, Volume: 7, Issue:4

    Topics: Ammonia; Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis, Experimental

1993
Increased densities of binding sites for the peripheral-type benzodiazepine receptor ligand [3H]PK 11195 in congenital ornithine transcarbamylase-deficient sparse fur mouse.
    Pediatric research, 1993, Volume: 34, Issue:6

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Binding Sites; Brain; Disease Models, Animal

1993
Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:5

    Topics: Ammonia; Animals; Behavior, Animal; Blood Urea Nitrogen; Disease Models, Animal; Hepatic Encephalopa

1994
Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study.
    Liver, 1994, Volume: 14, Issue:1

    Topics: Ammonia; Animals; Brain Edema; Disease Models, Animal; Electroencephalography; Hepatic Encephalopath

1994
Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene.
    Somatic cell and molecular genetics, 1994, Volume: 20, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Ammonia; Animals; Argininosuccinate Synthase; Cel

1994
Gender-dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt.
    Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:2

    Topics: Amino Acids; Ammonia; Animals; Body Weight; Disease Models, Animal; Eating; Female; Hepatic Encephal

1994
Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Biochemical pharmacology, 1993, Jan-07, Volume: 45, Issue:1

    Topics: Acetyl Coenzyme A; Adenosine Triphosphate; Ammonia; Animals; Benzoates; Benzoic Acid; Brain; Coenzym

1993
Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoate.
    Biochemical and molecular medicine, 1995, Volume: 54, Issue:2

    Topics: Acetyl Coenzyme A; Ammonia; Animals; Benzoates; Benzoic Acid; Chronic Disease; Coenzyme A; Disease M

1995
Rats with gastritis have increased sensitivity to the gastrin stimulatory effects of luminal ammonia.
    Gastroenterology, 1996, Volume: 110, Issue:3

    Topics: Acetates; Ammonia; Animals; Disease Models, Animal; Gastric Mucosa; Gastrins; Gastritis; Iodoacetami

1996
Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats.
    Nature medicine, 1996, Volume: 2, Issue:8

    Topics: Administration, Oral; Ammonia; Animals; Capsules; Disease Models, Animal; Escherichia coli; Feasibil

1996
Tyrosine uptake and regional brain monoamine metabolites in a rat model resembling congenital hyperammonemia.
    Pediatric research, 1996, Volume: 39, Issue:6

    Topics: Amino Acids; Ammonia; Animals; Body Weight; Brain; Disease Models, Animal; Dopamine; Eating; Homovan

1996
The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Gene therapy, 1995, Volume: 2, Issue:10

    Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Ammonia; Animals; Avoidance Learning; Crosses, Ge

1995
Electrodermal response in nonglabrous skin of freely moving rats: mediation by the sympathetic nervous system and evaluation in an animal model of depression.
    Neuropsychobiology, 1996, Volume: 33, Issue:3

    Topics: Ammonia; Animals; Depressive Disorder; Disease Models, Animal; Facial Nerve; Galvanic Skin Response;

1996
Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse.
    Brain research. Developmental brain research, 1995, Dec-21, Volume: 90, Issue:1-2

    Topics: Ammonia; Animals; Brain Damage, Chronic; Disease Models, Animal; Glutamine; Hair; Metabolism, Inborn

1995
Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain.
    Brain research, 1995, Dec-24, Volume: 705, Issue:1-2

    Topics: Acetates; Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Liver Failure, Ac

1995
Comparison of the metabolic disturbances caused by end-to-side and side-to-side portacaval shunts.
    Journal of applied physiology (Bethesda, Md. : 1985), 1996, Volume: 80, Issue:3

    Topics: Amino Acids; Ammonia; Animals; Blood Glucose; Body Weight; Brain; Disease Models, Animal; Hepatic En

1996
Live E. coli cells to treat uremia.
    Nature medicine, 1997, Volume: 3, Issue:1

    Topics: Administration, Oral; Ammonia; Animals; Disease Models, Animal; Escherichia coli; Genetic Engineerin

1997
Precipitation of overt encephalopathy in the portacaval shunted rat: towards the development of an adequate model of chronic portal systemic encephalopathy.
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:3

    Topics: Ammonia; Animals; Blood Urea Nitrogen; Body Weight; Disease Models, Animal; Feasibility Studies; Hep

1997
Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:4

    Topics: Ammonia; Animals; Body Water; Brain; Disease Models, Animal; Electroencephalography; Glutamic Acid;

1997
Two models of acute hepatic failure with extensive hepatic necrosis and blood ammonia elevation in small animals.
    Journal of medicine, 1997, Volume: 28, Issue:1-2

    Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Common Bile Duct; Disease Models, Animal; Emulsio

1997
Developmental study of hepatic glutamine synthetase in a mouse model of congenital hyperammonemia.
    Biochemistry and molecular biology international, 1997, Volume: 43, Issue:1

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Body Weight; Disease Models, Animal; Female;

1997
Loss and recovery of liver regeneration in rats with fulminant hepatic failure.
    The Journal of surgical research, 1997, Volume: 72, Issue:2

    Topics: Albumins; Ammonia; Animals; Bilirubin; Cell Division; Cell Transplantation; Disease Models, Animal;

1997
Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    The International journal of artificial organs, 1998, Volume: 21, Issue:1

    Topics: Adenosine Triphosphate; Amino Acids; Ammonia; Animals; Bioreactors; Cell Adhesion; Cells, Cultured;

1998
Evaluation of gene therapy for citrullinaemia using murine and bovine models.
    Journal of inherited metabolic disease, 1998, Volume: 21 Suppl 1

    Topics: Adenoviruses, Human; Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Arginine; Argininosucci

1998
Region-specific changes in CNS muscarinic acetylcholine receptors in a rat model of hyperammonemia.
    Biochemical pharmacology, 1998, Jul-15, Volume: 56, Issue:2

    Topics: Ammonia; Animals; Brain; Disease Models, Animal; Kinetics; Quinuclidinyl Benzilate; Rats; Rats, Wist

1998
Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
    Metabolic brain disease, 1998, Volume: 13, Issue:3

    Topics: Ammonia; Animals; Benzodiazepines; Chronic Disease; Disease Models, Animal; Dogs; Electroencephalogr

1998
Mice deficient in the urea-cycle enzyme, carbamoyl phosphate synthetase I, die during the early neonatal period from hyperammonemia.
    Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:1

    Topics: Amino Acid Sequence; Ammonia; Animals; Animals, Newborn; Base Sequence; Brain; Carbamoyl-Phosphate S

1999
Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:6

    Topics: Ammonia; Animals; Anti-Ulcer Agents; Carbon Tetrachloride; Disease Models, Animal; Diterpenes; Gastr

1999
In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure.
    Life sciences, 1999, Volume: 65, Issue:26

    Topics: Ammonia; Animals; Cattle; Dialysis; Disease Models, Animal; Drug Carriers; Erythrocytes; Glutamate D

1999
A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig.
    The Journal of surgical research, 2000, Volume: 88, Issue:2

    Topics: Acute Disease; Ammonia; Animals; Disease Models, Animal; Ischemia; Liver; Liver Failure; Male; Swine

2000
[Effect of ammonia on the pig respiratory system. Study of the dose-response relation].
    Bulletin et memoires de l'Academie royale de medecine de Belgique, 1999, Volume: 154, Issue:6 Pt 2

    Topics: Air Pollutants; Ammonia; Animals; Bronchial Hyperreactivity; Capillary Permeability; Cough; Disease

1999
A novel stable reproducible model of hepatic failure in canines.
    The Journal of surgical research, 2000, Volume: 94, Issue:2

    Topics: Alanine Transaminase; Amino Acids, Branched-Chain; Amino Acids, Cyclic; Ammonia; Animals; Aspartate

2000
Diabetogenic role of insulin's counterregulatory hormones in the isletectomized, diabetic goby.
    Endocrine, 2000, Volume: 13, Issue:3

    Topics: Ammonia; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal

2000
Long-term ammonium chloride or sodium bicarbonate treatment in two models of polycystic kidney disease.
    Experimental nephrology, 2001, Volume: 9, Issue:3

    Topics: Ammonia; Ammonium Chloride; Animals; Bicarbonates; Disease Models, Animal; Female; Fibrosis; Inflamm

2001
Heliox use in the treatment of acute hyperammonemia.
    Journal of child neurology, 2001, Volume: 16, Issue:6

    Topics: Administration, Inhalation; Ammonia; Animals; Disease Models, Animal; Drug Evaluation, Preclinical;

2001
Effects of prostaglandin E(1) on the efficacy of xenogeneic extracorporeal pig liver perfusion in a canine model of acute liver failure.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:6

    Topics: Alprostadil; Amino Acids; Amino Acids, Branched-Chain; Ammonia; Animals; Bile; Bile Acids and Salts;

2001
Fermentable carbohydrate and digestive nitrogen excretion.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2001, Volume: 11, Issue:3

    Topics: Ammonia; Animals; Cecum; Dietary Carbohydrates; Dietary Proteins; Disease Models, Animal; Disease Pr

2001
In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
    Cell transplantation, 2001, Volume: 10, Issue:4-5

    Topics: Ammonia; Animals; Blood Coagulation; Disease Models, Animal; Glucose; Glutamate-Ammonia Ligase; Glut

2001
[Nitrogen detoxification in artificially-fed zinc-deficient rats].
    Journal of animal physiology and animal nutrition, 2001, Volume: 85, Issue:5-6

    Topics: Alkaline Phosphatase; Ammonia; Animals; Arginase; Argininosuccinate Lyase; Argininosuccinate Synthas

2001
The treatment of ammonia poisoning by taurine in combination with a broncholytic drug.
    Advances in experimental medicine and biology, 2000, Volume: 483

    Topics: Administration, Inhalation; Ammonia; Animals; Antidotes; Antioxidants; Bronchodilator Agents; Diseas

2000
Establishment of an animal model of chronic atrophic gastritis and a study on the factors inducing atrophy.
    Chinese medical journal, 2001, Volume: 114, Issue:12

    Topics: Ammonia; Animals; Atrophy; Deoxycholic Acid; Disease Models, Animal; Ethanol; Gastric Mucosa; Gastri

2001
[Metabolic disorders in experimental hepatic insufficiency and parenteral feeding].
    Annales de l'anesthesiologie francaise, 1977, Volume: 18, Issue:11

    Topics: 5-Hydroxytryptophan; Amino Acids; Ammonia; Animals; Blood Coagulation; Blood Transfusion; Choline; D

1977
Primary dilation of the cerebral resistance vessels as a cause of increased intracranial pressure.
    Advances in neurology, 1978, Volume: 20

    Topics: Acute Disease; Ammonia; Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Electro

1978
Comparison of mild vs severe pressure overload on the enzymatic activity of myosin in the canine ventricles.
    Biochemical medicine, 1975, Volume: 14, Issue:2

    Topics: Adenosine Triphosphatases; Ammonia; Animals; Blood Pressure; Calcium; Disease Models, Animal; Dogs;

1975
Hyperammonemic coma after hepatectomy in germ-free rats.
    Gastroenterology, 1979, Volume: 77, Issue:2

    Topics: Ammonia; Animals; Bacteria; Bacterial Toxins; Disease Models, Animal; Germ-Free Life; Hepatectomy; H

1979
A model of fulminant hepatic failure in the rabbit.
    Gastroenterology, 1978, Volume: 74, Issue:4

    Topics: Alkaline Phosphatase; Amino Acids; Ammonia; Animals; Aspartate Aminotransferases; Blood Coagulation

1978
Hepatic metabolic changes following energy deprivation by ammonia in patients and rabbits with jaundice.
    Surgery, gynecology & obstetrics, 1977, Volume: 145, Issue:1

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Ammonia; Ammonium Chloride;

1977
Experience of treatment in the Amanita phalloides poisoning (clinical and experimental observations).
    Current problems in clinical biochemistry, 1977, Volume: 7

    Topics: Adolescent; Adult; Alanine Transaminase; Amanita; Ammonia; Animals; Aspartate Aminotransferases; Bio

1977
Histochemical studies in experimental portal-systemic encephalopathy.
    Archives of neurology, 1976, Volume: 33, Issue:4

    Topics: Alzheimer Disease; Ammonia; Animals; Cerebral Cortex; Disease Models, Animal; Glutamate Dehydrogenas

1976
Effect of ammonia on cerebral metabolism of rats with portocaval shunts.
    Transactions of the American Neurological Association, 1976, Volume: 101

    Topics: Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Male; Portacaval Shunt, Sur

1976
Total devascularization of the Liver: an experimental model of acute liver failure.
    Scandinavian journal of gastroenterology. Supplement, 1976, Volume: 37

    Topics: Acute Disease; Ammonia; Animals; Disease Models, Animal; Glucose; Lactates; Liver; Liver Diseases; P

1976
Projections and measurements of in vivo performance of liquid membrane capsules.
    Kidney international. Supplement, 1976, Issue:7

    Topics: Ammonia; Animals; Capsules; Disease Models, Animal; Dogs; In Vitro Techniques; Intestine, Small; Mem

1976
Methionine-induced hepatic coma in dogs.
    American journal of surgery, 1975, Volume: 130, Issue:1

    Topics: Administration, Oral; Ammonia; Animals; Brain; Disease Models, Animal; Dogs; Hepatic Encephalopathy;

1975
Quinolinate in brain and cerebrospinal fluid in rat models of congenital hyperammonemia.
    Pediatric research, 1992, Volume: 32, Issue:4

    Topics: Acetates; Ammonia; Animals; Brain; Disease Models, Animal; Hydroxyindoleacetic Acid; Male; Metabolis

1992
The isolated perfused rat liver as an experimental model.
    The American surgeon, 1992, Volume: 58, Issue:9

    Topics: Albumins; Amino Acids; Ammonia; Animals; Biological Availability; Disease Models, Animal; Evaluation

1992
Interactions of ibuprofen with influenza infection and hyperammonemia in an animal model of Reye's syndrome.
    Pediatric research, 1992, Volume: 31, Issue:3

    Topics: Alanine Transaminase; Ammonia; Animals; Arginine; Aspartate Aminotransferases; Diet; Disease Models,

1992
A reliable method for the production of antral gastric ulcer by a combination of 2-deoxy-D-glucose, aspirin and ammonia in rats.
    Japanese journal of pharmacology, 1991, Volume: 56, Issue:4

    Topics: Administration, Oral; Ammonia; Animals; Aspirin; Deoxyglucose; Disease Models, Animal; Drug Interact

1991
A new surgical model of acute liver failure in the pig: experimental procedure and analysis of liver injury.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1991, Volume: 23, Issue:1

    Topics: Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Female; Hepatectom

1991
Congenital portosystemic shunts (PSS) in dogs are a genetic disorder.
    Tijdschrift voor diergeneeskunde, 1991, Volume: 116 Suppl 1

    Topics: Ammonia; Animals; Disease Models, Animal; Dog Diseases; Dogs; Female; Hepatic Encephalopathy; Male;

1991
In vivo and in vitro rat model for cyclosporine-induced proximal tubular toxicity.
    The Journal of laboratory and clinical medicine, 1991, Volume: 118, Issue:1

    Topics: Acetylglucosaminidase; Ammonia; Animals; Citrates; Citric Acid; Cyclosporins; Disease Models, Animal

1991
[Possibilities of hemosorption using a fibrous sorbent in acute hepatic failure (experimental study)].
    Khirurgiia, 1990, Issue:12

    Topics: Acrylic Resins; Acute Disease; Ammonia; Animals; Bilirubin; Blood Proteins; Disease Models, Animal;

1990
The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Brain & development, 1990, Volume: 12, Issue:4

    Topics: Ammonia; Animals; Blood Glucose; Carnitine; Disease Models, Animal; Fatty Acids, Monounsaturated; Fa

1990
Gas-exchange impairment: its correlation to lung mechanics in acute airway obstruction (studies on a rabbit asthma model).
    Clinical physiology (Oxford, England), 1990, Volume: 10, Issue:4

    Topics: Airway Obstruction; Ammonia; Animals; Asthma; Bronchi; Bronchial Provocation Tests; Disease Models,

1990
The effect of blood ingestion on brain serotonin synthesis in portacaval-shunted rats.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1987, Volume: 187, Issue:5

    Topics: 5-Hydroxytryptophan; Amino Acids; Ammonia; Animals; Blood; Brain; Disease Models, Animal; Explorator

1987
Ammonia-complement interaction in the pathogenesis of progressive renal injury.
    Kidney international. Supplement, 1989, Volume: 27

    Topics: Ammonia; Animals; Complement System Proteins; Disease Models, Animal; Drug Interactions; Humans; Kid

1989
Alterations in plasma amino acids and hepatic enzymes in the 4-pentenoic acid model of Reye's syndrome.
    Biochemical pharmacology, 1989, May-15, Volume: 38, Issue:10

    Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Fatty Acids, Monounsaturated; Glutamate Dehyd

1989
A simple animal model of hyperammonemia.
    Hepatology (Baltimore, Md.), 1989, Volume: 10, Issue:3

    Topics: Acetates; Ammonia; Animals; Citrulline; Disease Models, Animal; Glutamate Dehydrogenase; Liver; Male

1989
Reduced somatostatin-like immunoreactivity in the brain of dogs with an Eck fistula.
    Regulatory peptides, 1987, Volume: 18, Issue:5-6

    Topics: Amino Acids; Ammonia; Animals; Chromatography, Gel; Disease Models, Animal; Dogs; Hepatic Encephalop

1987
Brain cholecystokinin depletion in rats with acute liver failure.
    Life sciences, 1989, Volume: 44, Issue:2

    Topics: Ammonia; Animals; Blood Glucose; Brain; Cerebral Cortex; Cholecystokinin; Disease Models, Animal; Hy

1989
Continuous intravenous ammonia infusion as a model for the study of hepatic encephalopathy in rabbits.
    The Journal of surgical research, 1989, Volume: 46, Issue:3

    Topics: Acetates; Acetic Acid; Ammonia; Animals; Blood Glucose; Disease Models, Animal; Electroencephalograp

1989
Arginine deficiency, hyperammonemia and Reye's syndrome in ferrets.
    Laboratory animal science, 1985, Volume: 35, Issue:3

    Topics: Ammonia; Animals; Animals, Laboratory; Arginine; Carnivora; Disease Models, Animal; Ferrets; Influen

1985
Correlation between electroencephalographic and biochemical indices in acute hepatic encephalopathy in rats.
    Journal of hepatology, 1987, Volume: 4, Issue:3

    Topics: Acute Disease; Alanine Transaminase; Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroe

1987
A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1987, Volume: 19, Issue:5

    Topics: Ammonia; Animals; Blood Coagulation Factors; Disease Models, Animal; Electroencephalography; Female;

1987
Differences in virulence within the species Bacteroides gingivalis.
    Antonie van Leeuwenhoek, 1987, Volume: 53, Issue:4

    Topics: Ammonia; Animals; Bacteroides; Bacteroides Infections; Blood Bactericidal Activity; Disease Models,

1987
Behavioral and neurotransmitter changes in the urease-infused rat: a model of congenital hyperammonemia.
    Pediatric research, 1986, Volume: 20, Issue:12

    Topics: Ammonia; Animals; Behavior, Animal; Biogenic Amines; Brain; Disease Models, Animal; Drug Implants; F

1986
A reproducible model of acute hepatic failure by transient ischemia in the pig.
    The Journal of surgical research, 1987, Volume: 42, Issue:1

    Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroencephalography; Electrophysiology; Fi

1987
Biochemical and morphological characteristics of a mouse model of Reye's syndrome induced by the interaction of influenza B virus and a chemical emulsifier.
    Laboratory investigation; a journal of technical methods and pathology, 1986, Volume: 54, Issue:1

    Topics: Ammonia; Animals; Animals, Suckling; Disease Models, Animal; Emulsions; Female; Influenza B virus; L

1986
Metabolic and mitochondrial morphological changes that mimic Reye syndrome after endotoxin administration to rats.
    Infection and immunity, 1985, Volume: 47, Issue:1

    Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Blood Glucose; Disease Models,

1985
Neuron-specific mitochondrial degeneration induced by hyperammonemia and octanoic acidemia.
    Brain research, 1985, Aug-12, Volume: 340, Issue:2

    Topics: Ammonia; Animals; Brain; Caprylates; Disease Models, Animal; Dogs; In Vitro Techniques; Mitochondria

1985
The pathophysiology of hyperchloremic metabolic acidosis after urinary diversion through intestinal segments.
    Surgery, 1985, Volume: 98, Issue:3

    Topics: Acidosis; Ammonia; Animals; Chlorides; Disease Models, Animal; Dogs; Electrolytes; Female; Ileum; Ki

1985
Investigation of an animal model of a Reye-like syndrome caused by Margosa oil.
    Pediatric research, 1985, Volume: 19, Issue:12

    Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Blood Glucose; Brain Edema; Dis

1985
Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Biochemistry international, 1985, Volume: 11, Issue:5

    Topics: Aging; Ammonia; Animals; Body Weight; Disease Models, Animal; Hair; Liver; Mice; Mice, Mutant Strain

1985
Renal ammoniagenesis and tissue glutamine, glutamine synthetase, and glutaminase I levels in potassium-deficient rats.
    The Journal of laboratory and clinical medicine, 1973, Volume: 82, Issue:2

    Topics: Ammonia; Animals; Carbon Dioxide; Chlorides; Disease Models, Animal; Glutamate-Ammonia Ligase; Gluta

1973
Urease-inhibiting action of some drugs in vitro and in vivo.
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:3

    Topics: Ammonia; Animals; Anti-Bacterial Agents; Ascorbic Acid; Bacitracin; Chloramphenicol; Chlortetracycli

1970
The astrocyte response in experimental portal-systemic encephalopathy: an electron microscopic study.
    Journal of neuropathology and experimental neurology, 1974, Volume: 33, Issue:3

    Topics: Ammonia; Animals; Cell Membrane; Cell Nucleus; Cerebral Cortex; Cytoplasm; Cytoplasmic Granules; Dis

1974
Experimental ammonia encephalopathy in the primate.
    Archives of neurology, 1972, Volume: 26, Issue:2

    Topics: Ammonia; Animals; Brain; Brain Diseases; Disease Models, Animal; Electroencephalography; Haplorhini;

1972
The Eck fistula rat: definition of an experimental model.
    European journal of clinical investigation, 1972, Volume: 2, Issue:6

    Topics: Adrenal Glands; Ammonia; Animals; Atrophy; Body Weight; Cerebral Cortex; Coprophagia; Disease Models

1972
Ultrastructural responses of the astrocytes to portocaval anastomosis in the rat.
    Journal of the neurological sciences, 1973, Volume: 18, Issue:1

    Topics: Ammonia; Animals; Brain; Brain Diseases; Carbon Tetrachloride Poisoning; Caudate Nucleus; Cerebellar

1973
Effects of colectomy on encephalopathy in rats with protacaval shunts.
    Surgery, gynecology & obstetrics, 1974, Volume: 138, Issue:4

    Topics: Ammonia; Animals; Brain Diseases; Colectomy; Colon; Disease Models, Animal; Electroencephalography;

1974
Abnormal orotic acid metabolism associated with acute hyperammonaemia in the rat.
    Biochemical medicine, 1974, Volume: 9, Issue:1

    Topics: Acetates; Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Carbon Radioisotopes; Carboxy-Lyas

1974
Brain histology and behavior of mice injected with urease.
    Journal of neuropathology and experimental neurology, 1974, Volume: 33, Issue:2

    Topics: Ammonia; Animals; Behavior, Animal; Body Temperature; Brain; Brain Chemistry; Cell Nucleus; Disease

1974
Changes in energy state and acid-base parameters of the rat brain during complete compression ischemia.
    Brain research, 1974, Jun-20, Volume: 73, Issue:2

    Topics: Acid-Base Equilibrium; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosp

1974
Cerebral metabolic state following complete compression ischemia.
    Brain research, 1974, Jun-20, Volume: 73, Issue:2

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Amino Acids; Ammo

1974
An experimental model for the study of hepatic encephalopathy.
    Archives of neurology, 1974, Volume: 31, Issue:2

    Topics: Ammonia; Animals; Bilirubin; Blood Glucose; Cell Nucleolus; Cell Nucleus; Cerebral Cortex; Disease M

1974
Effect of low protein diet and hyperammonemia on liver glutaminase activity in the rat.
    Experientia, 1974, Apr-15, Volume: 30, Issue:4

    Topics: Acetates; Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; Body Weight; Dietary Proteins; Dis

1974
Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure.
    Gut, 1974, Volume: 15, Issue:6

    Topics: Ammonia; Animals; Bilirubin; Carbon Radioisotopes; Charcoal; Disease Models, Animal; Dogs; Filtratio

1974
Renal metabolism of glutamine in dogs during infusion of -ketoglutaric acid.
    The American journal of physiology, 1972, Volume: 222, Issue:3

    Topics: Acidosis; Ammonia; Ammonium Chloride; Animals; Cell Membrane Permeability; Disease Models, Animal; D

1972
Experimental prepatent schistosomiasis mansoni: quantitative analyses of proteins, enzyme activity and free amino acids in mouse serum.
    Experimental parasitology, 1972, Volume: 31, Issue:3

    Topics: Alanine Transaminase; Alkaline Phosphatase; Amino Acids; Ammonia; Animals; Aspartate Aminotransferas

1972
Acute hepatic coma: a canine model.
    Surgery, 1972, Volume: 72, Issue:4

    Topics: Ammonia; Animals; Aspartate Aminotransferases; Blood Coagulation Tests; Blood Pressure; Blood Urea N

1972
Changes in the cerebellar cortex in rats after portocaval anastomosis.
    Journal of the neurological sciences, 1972, Volume: 15, Issue:1

    Topics: Ammonia; Animals; Cerebellar Cortex; Cerebellar Diseases; Dementia; Dendrites; Disease Models, Anima

1972
Eck's fistula encephalopathy in germfree dogs.
    Annals of surgery, 1971, Volume: 174, Issue:5

    Topics: Ammonia; Animals; Body Weight; Brain; Brain Diseases; Disease Models, Animal; Dogs; Germ-Free Life;

1971
[Modification of experimentally induced endogenous hyperammoniemia by amino acids in the rat].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:3

    Topics: Amino Acids; Ammonia; Anesthesia, General; Animals; Arginine; Aspartic Acid; Citric Acid Cycle; Depr

1970
Eck fistula encephalopathy: long-term studies in primates.
    Annals of surgery, 1971, Volume: 173, Issue:1

    Topics: Ammonia; Animals; Body Weight; Brain; Brain Diseases; Dietary Proteins; Disease Models, Animal

1971
Hemodialysis of ammonium nitrogen.
    Surgery, gynecology & obstetrics, 1971, Volume: 132, Issue:4

    Topics: Ammonia; Animals; Disease Models, Animal; Dogs; Extracorporeal Circulation; Hepatic Encephalopathy;

1971
[Encephalopathy of the rat with portacaval shunt: an animal model for therapeutic experiments].
    Schweizerische medizinische Wochenschrift, 1971, May-22, Volume: 101, Issue:20

    Topics: Ammonia; Animals; Body Weight; Brain Diseases; Carbohydrates; Disease Models, Animal; Motor Activity

1971